|
☒
|
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
☐
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Virginia
|
|
52-1549373
|
||||
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
||||
4991 Lake Brook Drive,
|
Suite 100
|
|
|
|
||
|
Glen Allen,
|
Virginia
|
|
23060-9245
|
||
(Address of principal executive offices)
|
|
(Zip Code)
|
||||
|
|
|
(804)
|
217-5800
|
|
|
(Registrant’s telephone number, including area code)
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
||
Title of each class
|
|
Trading symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, $.01 par value
|
|
DX
|
|
New York Stock Exchange
|
8.50% Series A Cumulative Redeemable Preferred Stock, par value $0.01 per share
|
|
DXPRA
|
|
New York Stock Exchange
|
7.625% Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share
|
|
DXPRB
|
|
New York Stock Exchange
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☒
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☐
|
|
|
Emerging growth company
|
☐
|
|
|
|
Page
|
|
|||
|
|
|
|
|
|
||
|
|
|
|
|
|
Consolidated Balance Sheets as of June 30, 2019 (unaudited) and December 31, 2018
|
|
|
|
|
|
|
|
Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2019 (unaudited) and June 30, 2018 (unaudited)
|
|
|
|
|
|
|
|
Consolidated Statements of Shareholders' Equity for the three and six months ended June 30, 2019 and June 30, 2018 (unaudited)
|
|
|
|
|
|
|
|
Consolidated Statements of Cash Flows for the six months ended June 30, 2019 (unaudited) and June 30, 2018 (unaudited)
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
|
June 30, 2019
|
|
December 31, 2018
|
||||
ASSETS
|
(unaudited)
|
|
|
||||
Mortgage-backed securities (including pledged of $5,132,400 and $3,511,604 respectively)
|
$
|
5,713,788
|
|
|
$
|
3,749,464
|
|
Mortgage loans held for investment, net
|
10,306
|
|
|
11,527
|
|
||
Cash and cash equivalents
|
49,956
|
|
|
34,598
|
|
||
Restricted cash
|
61,394
|
|
|
54,106
|
|
||
Derivative assets
|
342
|
|
|
6,563
|
|
||
Receivable for securities sold
|
1,242
|
|
|
—
|
|
||
Accrued interest receivable
|
25,292
|
|
|
21,019
|
|
||
Other assets, net
|
6,565
|
|
|
8,812
|
|
||
Total assets
|
$
|
5,868,885
|
|
|
$
|
3,886,089
|
|
|
|
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
||
Liabilities:
|
|
|
|
|
|
||
Repurchase agreements
|
$
|
4,815,452
|
|
|
$
|
3,267,984
|
|
Payable for unsettled securities
|
425,897
|
|
|
58,915
|
|
||
Non-recourse collateralized financing
|
3,078
|
|
|
3,458
|
|
||
Derivative liabilities
|
207
|
|
|
1,218
|
|
||
Accrued interest payable
|
15,907
|
|
|
10,308
|
|
||
Accrued dividends payable
|
7,164
|
|
|
13,810
|
|
||
Other liabilities
|
2,542
|
|
|
3,243
|
|
||
Total liabilities
|
5,270,247
|
|
|
3,358,936
|
|
||
|
|
|
|
|
|||
Shareholders’ equity:
|
|
|
|
|
|
||
Preferred stock, par value $.01 per share; 50,000,000 shares authorized; 6,514,130 and 5,954,594 shares issued and outstanding, respectively ($162,853 and $148,865 aggregate liquidation preference, respectively)
|
$
|
156,071
|
|
|
$
|
142,883
|
|
Common stock, par value $.01 per share, 90,000,000 shares authorized;
24,646,964 and 20,939,073 shares issued and outstanding, respectively
|
246
|
|
|
209
|
|
||
Additional paid-in capital
|
882,633
|
|
|
818,861
|
|
||
Accumulated other comprehensive income (loss)
|
161,815
|
|
|
(35,779
|
)
|
||
Accumulated deficit
|
(602,127
|
)
|
|
(399,021
|
)
|
||
Total shareholders’ equity
|
598,638
|
|
|
527,153
|
|
||
Total liabilities and shareholders’ equity
|
$
|
5,868,885
|
|
|
$
|
3,886,089
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Interest income
|
$
|
43,748
|
|
|
$
|
25,922
|
|
|
$
|
83,706
|
|
|
$
|
51,112
|
|
Interest expense
|
30,813
|
|
|
14,175
|
|
|
57,089
|
|
|
25,770
|
|
||||
Net interest income
|
12,935
|
|
|
11,747
|
|
|
26,617
|
|
|
25,342
|
|
||||
|
|
|
|
|
|
|
|
|
|||||||
(Loss) gain on derivative instruments, net
|
(117,535
|
)
|
|
20,667
|
|
|
(179,233
|
)
|
|
59,021
|
|
||||
Loss on sale of investments, net
|
(10,360
|
)
|
|
(12,444
|
)
|
|
(10,360
|
)
|
|
(16,219
|
)
|
||||
Fair value adjustments, net
|
(16
|
)
|
|
27
|
|
|
(29
|
)
|
|
56
|
|
||||
Other operating income (expense), net
|
256
|
|
|
(339
|
)
|
|
25
|
|
|
(592
|
)
|
||||
General and administrative expenses:
|
|
|
|
|
|
|
|
||||||||
Compensation and benefits
|
(1,747
|
)
|
|
(1,751
|
)
|
|
(3,645
|
)
|
|
(3,713
|
)
|
||||
Other general and administrative
|
(2,518
|
)
|
|
(2,255
|
)
|
|
(4,574
|
)
|
|
(3,936
|
)
|
||||
Net (loss) income
|
(118,985
|
)
|
|
15,652
|
|
|
(171,199
|
)
|
|
59,959
|
|
||||
Preferred stock dividends
|
(3,206
|
)
|
|
(2,942
|
)
|
|
(6,265
|
)
|
|
(5,882
|
)
|
||||
Net (loss) income to common shareholders
|
$
|
(122,191
|
)
|
|
$
|
12,710
|
|
|
$
|
(177,464
|
)
|
|
$
|
54,077
|
|
|
|
|
|
|
|
|
|
||||||||
Other comprehensive income:
|
|
|
|
|
|
|
|
||||||||
Unrealized gain (loss) on available-for-sale investments, net
|
$
|
100,767
|
|
|
$
|
(22,156
|
)
|
|
$
|
187,399
|
|
|
$
|
(71,345
|
)
|
Reclassification adjustment for loss on sale of investments, net
|
10,360
|
|
|
12,444
|
|
|
10,360
|
|
|
16,219
|
|
||||
Reclassification adjustment for de-designated cash flow hedges
|
—
|
|
|
(48
|
)
|
|
(165
|
)
|
|
(96
|
)
|
||||
Total other comprehensive income (loss)
|
111,127
|
|
|
(9,760
|
)
|
|
197,594
|
|
|
(55,222
|
)
|
||||
Comprehensive (loss) income to common shareholders
|
$
|
(11,064
|
)
|
|
$
|
2,950
|
|
|
$
|
20,130
|
|
|
$
|
(1,145
|
)
|
|
|
|
|
|
|
|
|
||||||||
Net (loss) income per common share-basic and diluted
|
$
|
(4.98
|
)
|
|
$
|
0.68
|
|
|
$
|
(7.49
|
)
|
|
$
|
2.89
|
|
Weighted average common shares-basic and diluted
|
24,541
|
|
|
18,765
|
|
|
23,681
|
|
|
18,695
|
|
|
For the Three and Six Months Ended June 30, 2019
|
||||||||||||||||||||||||||
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Other
Comprehensive
(Loss) Income
|
|
Accumulated
Deficit
|
|
Total Shareholders’ Equity
|
||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||
Balance as of
December 31, 2018
|
5,954,594
|
|
$
|
142,883
|
|
|
20,939,073
|
|
$
|
209
|
|
|
$
|
818,861
|
|
|
$
|
(35,779
|
)
|
|
$
|
(399,021
|
)
|
|
$
|
527,153
|
|
Stock issuance
|
213,468
|
|
5,015
|
|
|
3,109,047
|
|
31
|
|
|
53,841
|
|
|
—
|
|
|
—
|
|
|
58,887
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
50,821
|
|
1
|
|
|
297
|
|
|
—
|
|
|
—
|
|
|
298
|
|
||||||
Adjustments for tax withholding on share-based compensation
|
—
|
|
—
|
|
|
(16,231
|
)
|
—
|
|
|
(296
|
)
|
|
—
|
|
|
—
|
|
|
(296
|
)
|
||||||
Stock issuance costs
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
(212
|
)
|
|
—
|
|
|
—
|
|
|
(212
|
)
|
||||||
Net loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,214
|
)
|
|
(52,214
|
)
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,059
|
)
|
|
(3,059
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12,350
|
)
|
|
(12,350
|
)
|
||||||
Other comprehensive income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
86,467
|
|
|
—
|
|
|
86,467
|
|
||||||
Balance as of
March 31, 2019
|
6,168,062
|
|
$
|
147,898
|
|
|
24,082,710
|
|
$
|
241
|
|
|
$
|
872,491
|
|
|
$
|
50,688
|
|
|
$
|
(466,644
|
)
|
|
$
|
604,674
|
|
Stock issuance
|
346,068
|
|
8,173
|
|
|
547,071
|
|
5
|
|
|
9,874
|
|
|
—
|
|
|
—
|
|
|
18,052
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
17,183
|
|
—
|
|
|
296
|
|
|
—
|
|
|
—
|
|
|
296
|
|
||||||
Stock issuance costs
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
(28
|
)
|
|
—
|
|
|
—
|
|
|
(28
|
)
|
||||||
Net loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(118,985
|
)
|
|
(118,985
|
)
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,206
|
)
|
|
(3,206
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(13,292
|
)
|
|
(13,292
|
)
|
||||||
Other comprehensive income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
111,127
|
|
|
—
|
|
|
111,127
|
|
||||||
Balance as of
June 30, 2019
|
6,514,130
|
|
$
|
156,071
|
|
|
24,646,964
|
|
$
|
246
|
|
|
$
|
882,633
|
|
|
$
|
161,815
|
|
|
$
|
(602,127
|
)
|
|
$
|
598,638
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
For the Three and Six Months Ended June 30, 2018
|
||||||||||||||||||||||||||
|
Preferred Stock
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Other
Comprehensive
Loss
|
|
Accumulated
Deficit
|
|
Total Shareholders’ Equity
|
||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||||||||
Balance as of
December 31, 2017
|
5,888,680
|
|
$
|
141,294
|
|
|
18,610,516
|
|
$
|
186
|
|
|
$
|
776,245
|
|
|
$
|
(8,697
|
)
|
|
$
|
(351,970
|
)
|
|
$
|
557,058
|
|
Stock issuance
|
20,319
|
|
494
|
|
|
15,133
|
|
—
|
|
|
294
|
|
|
—
|
|
|
—
|
|
|
788
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
58,745
|
|
1
|
|
|
334
|
|
|
—
|
|
|
—
|
|
|
335
|
|
||||||
Adjustments for tax withholding on share-based compensation
|
—
|
|
—
|
|
|
(19,045
|
)
|
—
|
|
|
(364
|
)
|
|
—
|
|
|
—
|
|
|
(364
|
)
|
||||||
Stock issuance costs
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
(19
|
)
|
|
—
|
|
|
—
|
|
|
(19
|
)
|
||||||
Net income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
44,307
|
|
|
44,307
|
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,940
|
)
|
|
(2,940
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,079
|
)
|
|
(10,079
|
)
|
||||||
Other comprehensive loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
(45,462
|
)
|
|
—
|
|
|
(45,462
|
)
|
Balance as of
March 31, 2018
|
5,908,999
|
|
$
|
141,788
|
|
|
18,665,349
|
|
$
|
187
|
|
|
$
|
776,490
|
|
|
$
|
(54,159
|
)
|
|
$
|
(320,682
|
)
|
|
$
|
543,624
|
|
Stock issuance
|
—
|
|
—
|
|
|
291,076
|
|
3
|
|
|
5,617
|
|
|
—
|
|
|
—
|
|
|
5,620
|
|
||||||
Restricted stock granted, net of amortization
|
—
|
|
—
|
|
|
12,308
|
|
—
|
|
|
294
|
|
|
—
|
|
|
—
|
|
|
294
|
|
||||||
Stock issuance costs
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
(11
|
)
|
|
—
|
|
|
—
|
|
|
(11
|
)
|
||||||
Net income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
15,652
|
|
|
15,652
|
|
||||||
Dividends on preferred stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,942
|
)
|
|
(2,942
|
)
|
||||||
Dividends on common stock
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10,243
|
)
|
|
(10,243
|
)
|
||||||
Other comprehensive loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
(9,760
|
)
|
|
—
|
|
|
(9,760
|
)
|
||||||
Balance as of
June 30, 2018
|
5,908,999
|
|
$
|
141,788
|
|
|
18,968,733
|
|
$
|
190
|
|
|
$
|
782,390
|
|
|
$
|
(63,919
|
)
|
|
$
|
(318,215
|
)
|
|
$
|
542,234
|
|
|
Six Months Ended
|
||||||
|
June 30,
|
||||||
|
2019
|
|
2018
|
||||
Operating activities:
|
|
|
|
||||
Net (loss) income
|
$
|
(171,199
|
)
|
|
$
|
59,959
|
|
Adjustments to reconcile net (loss) income to cash provided by operating activities:
|
|
|
|
|
|
||
(Increase) decrease in accrued interest receivable
|
(4,273
|
)
|
|
493
|
|
||
Increase in accrued interest payable
|
5,599
|
|
|
1,735
|
|
||
Loss (gain) on derivative instruments, net
|
179,233
|
|
|
(59,021
|
)
|
||
Loss on sale of investments, net
|
10,360
|
|
|
16,219
|
|
||
Fair value adjustments, net
|
29
|
|
|
(56
|
)
|
||
Amortization of investment premiums, net
|
63,239
|
|
|
74,136
|
|
||
Other amortization and depreciation, net
|
707
|
|
|
625
|
|
||
Stock-based compensation expense
|
593
|
|
|
629
|
|
||
Change in other assets and liabilities, net
|
642
|
|
|
(1,744
|
)
|
||
Net cash and cash equivalents provided by operating activities
|
84,930
|
|
|
92,975
|
|
||
Investing activities:
|
|
|
|
|
|
||
Purchase of investments
|
(2,100,712
|
)
|
|
(567,704
|
)
|
||
Principal payments received on investments
|
195,061
|
|
|
95,452
|
|
||
Proceeds from sales of investments
|
432,552
|
|
|
525,973
|
|
||
Principal payments received on mortgage loans held for investment, net
|
1,199
|
|
|
2,101
|
|
||
Net (payments) receipts on derivatives, including terminations
|
(174,023
|
)
|
|
54,050
|
|
||
Other investing activities
|
(1,348
|
)
|
|
(68
|
)
|
||
Net cash and cash equivalents (used in) provided by investing activities
|
(1,647,271
|
)
|
|
109,804
|
|
||
Financing activities:
|
|
|
|
|
|
||
Borrowings under repurchase agreements
|
60,627,601
|
|
|
54,577,482
|
|
||
Repayments of repurchase agreement borrowings
|
(59,080,133
|
)
|
|
(54,628,400
|
)
|
||
Principal payments on non-recourse collateralized financing
|
(386
|
)
|
|
(1,144
|
)
|
||
Proceeds from issuance of preferred stock
|
13,188
|
|
|
494
|
|
||
Proceeds from issuance of common stock
|
63,751
|
|
|
5,914
|
|
||
Cash paid for stock issuance costs
|
(185
|
)
|
|
—
|
|
||
Payments related to tax withholding for stock-based compensation
|
(296
|
)
|
|
(364
|
)
|
||
Dividends paid
|
(38,553
|
)
|
|
(26,003
|
)
|
||
Net cash and cash equivalents provided by (used in) financing activities
|
1,584,987
|
|
|
(72,021
|
)
|
||
|
|
|
|
||||
Net increase in cash, cash equivalents, and restricted cash
|
22,646
|
|
|
130,758
|
|
||
Cash, cash equivalents, and restricted cash at beginning of period
|
88,704
|
|
|
87,200
|
|
||
Cash, cash equivalents, and restricted cash at end of period
|
$
|
111,350
|
|
|
$
|
217,958
|
|
Supplemental Disclosure of Cash Activity:
|
|
|
|
|
|
||
Cash paid for interest
|
$
|
51,650
|
|
|
$
|
24,114
|
|
|
|
June 30, 2019
|
||
Cash and cash equivalents
|
|
$
|
49,956
|
|
Restricted cash
|
|
61,394
|
|
|
Total cash, cash equivalents, and restricted cash shown on consolidated statement of cash flows
|
|
$
|
111,350
|
|
|
June 30, 2019
|
|||||||||||||||||||||||||
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC (1)
|
|||||||||||||
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Agency
|
$
|
3,095,408
|
|
|
$
|
82,035
|
|
|
$
|
3,177,443
|
|
|
$
|
58,044
|
|
|
$
|
(2,184
|
)
|
|
$
|
3,233,303
|
|
|
3.97
|
%
|
Non-Agency
|
744
|
|
|
—
|
|
|
744
|
|
|
32
|
|
|
(19
|
)
|
|
757
|
|
|
6.75
|
%
|
||||||
|
3,096,152
|
|
|
82,035
|
|
|
3,178,187
|
|
|
58,076
|
|
|
(2,203
|
)
|
|
3,234,060
|
|
|
|
|||||||
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
1,875,117
|
|
|
15,793
|
|
|
1,890,910
|
|
|
91,994
|
|
|
(269
|
)
|
|
1,982,635
|
|
|
2.84
|
%
|
||||||
Non-Agency
|
1,422
|
|
|
(977
|
)
|
|
445
|
|
|
692
|
|
|
—
|
|
|
1,137
|
|
|
5.50
|
%
|
||||||
|
1,876,539
|
|
|
14,816
|
|
|
1,891,355
|
|
|
92,686
|
|
|
(269
|
)
|
|
1,983,772
|
|
|
|
|||||||
CMBS IO (2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
—
|
|
|
267,703
|
|
|
267,703
|
|
|
8,332
|
|
|
(108
|
)
|
|
275,927
|
|
|
0.66
|
%
|
||||||
Non-Agency
|
—
|
|
|
214,728
|
|
|
214,728
|
|
|
5,472
|
|
|
(171
|
)
|
|
220,029
|
|
|
0.63
|
%
|
||||||
|
—
|
|
|
482,431
|
|
|
482,431
|
|
|
13,804
|
|
|
(279
|
)
|
|
495,956
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Total AFS securities:
|
$
|
4,972,691
|
|
|
$
|
579,282
|
|
|
$
|
5,551,973
|
|
|
$
|
164,566
|
|
|
$
|
(2,751
|
)
|
|
$
|
5,713,788
|
|
|
|
(1)
|
The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
(2)
|
The notional balance for Agency CMBS IO and non-Agency CMBS IO was $12,861,382 and $10,014,205 respectively, as of June 30, 2019.
|
|
December 31, 2018
|
|||||||||||||||||||||||||
|
Par
|
|
Net Premium (Discount)
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Fair Value
|
|
WAC (1)
|
|||||||||||||
RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Agency
|
$
|
2,118,639
|
|
|
$
|
56,744
|
|
|
$
|
2,175,383
|
|
|
$
|
8,902
|
|
|
$
|
(26,264
|
)
|
|
$
|
2,158,021
|
|
|
3.95
|
%
|
Non-Agency
|
856
|
|
|
—
|
|
|
856
|
|
|
24
|
|
|
(22
|
)
|
|
858
|
|
|
6.75
|
%
|
||||||
|
2,119,495
|
|
|
56,744
|
|
|
2,176,239
|
|
|
8,926
|
|
|
(26,286
|
)
|
|
2,158,879
|
|
|
|
|||||||
CMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
1,071,906
|
|
|
8,518
|
|
|
1,080,424
|
|
|
6,141
|
|
|
(29,550
|
)
|
|
1,057,015
|
|
|
3.22
|
%
|
||||||
Non-Agency
|
3,040
|
|
|
(2,037
|
)
|
|
1,003
|
|
|
413
|
|
|
—
|
|
|
1,416
|
|
|
6.47
|
%
|
||||||
|
1,074,946
|
|
|
6,481
|
|
|
1,081,427
|
|
|
6,554
|
|
|
(29,550
|
)
|
|
1,058,431
|
|
|
|
|||||||
CMBS IO (2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Agency
|
—
|
|
|
287,062
|
|
|
287,062
|
|
|
4,281
|
|
|
(239
|
)
|
|
291,104
|
|
|
0.55
|
%
|
||||||
Non-Agency
|
—
|
|
|
240,681
|
|
|
240,681
|
|
|
1,675
|
|
|
(1,306
|
)
|
|
241,050
|
|
|
0.57
|
%
|
||||||
|
—
|
|
|
527,743
|
|
|
527,743
|
|
|
5,956
|
|
|
(1,545
|
)
|
|
532,154
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Total AFS securities:
|
$
|
3,194,441
|
|
|
$
|
590,968
|
|
|
$
|
3,785,409
|
|
|
$
|
21,436
|
|
|
$
|
(57,381
|
)
|
|
$
|
3,749,464
|
|
|
|
|
(1)
|
The WAC is the gross interest rate of the security weighted by the outstanding principal balance (or by notional balance in the case of an IO security).
|
(2)
|
The notional balance for the Agency CMBS IO and non-Agency CMBS IO was $13,048,666 and $10,275,494, respectively, as of December 31, 2018.
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
Less than 1 year
|
$
|
152,858
|
|
|
$
|
157,963
|
|
|
$
|
39,868
|
|
|
$
|
39,808
|
|
>1 and <5 years
|
285,275
|
|
|
289,174
|
|
|
151,041
|
|
|
152,917
|
|
||||
>5 and <10 years
|
879,723
|
|
|
914,413
|
|
|
828,543
|
|
|
806,015
|
|
||||
> 10 years
|
4,234,117
|
|
|
4,352,238
|
|
|
2,765,957
|
|
|
2,750,724
|
|
||||
|
$
|
5,551,973
|
|
|
$
|
5,713,788
|
|
|
$
|
3,785,409
|
|
|
$
|
3,749,464
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||||||||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||||||||||||||||||
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||||||||||||||||||
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
|
Proceeds Received
|
|
Realized Gain (Loss)
|
||||||||||||||||
Agency RMBS
|
$
|
205,493
|
|
|
$
|
(3,953
|
)
|
|
$
|
217,837
|
|
|
$
|
(7,785
|
)
|
|
$
|
205,493
|
|
|
$
|
(3,953
|
)
|
|
$
|
217,837
|
|
|
$
|
(7,785
|
)
|
Agency CMBS
|
213,198
|
|
|
(6,493
|
)
|
|
—
|
|
|
—
|
|
|
213,198
|
|
|
(6,493
|
)
|
|
108,758
|
|
|
(2,052
|
)
|
||||||||
Agency CMBS IO
|
13,861
|
|
|
86
|
|
|
—
|
|
|
—
|
|
|
13,861
|
|
|
86
|
|
|
—
|
|
|
—
|
|
||||||||
Non-Agency CMBS IO
|
—
|
|
|
—
|
|
|
8,695
|
|
|
51
|
|
|
—
|
|
|
—
|
|
|
8,695
|
|
|
51
|
|
||||||||
U.S. Treasuries
|
—
|
|
|
—
|
|
|
144,461
|
|
|
(4,710
|
)
|
|
—
|
|
|
—
|
|
|
190,960
|
|
|
(6,433
|
)
|
||||||||
|
$
|
432,552
|
|
|
$
|
(10,360
|
)
|
|
$
|
370,993
|
|
|
$
|
(12,444
|
)
|
|
$
|
432,552
|
|
|
$
|
(10,360
|
)
|
|
$
|
526,250
|
|
|
$
|
(16,219
|
)
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||||||
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|
# of Securities
|
||||||||
Continuous unrealized loss position for less than 12 months:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Agency MBS
|
$
|
148,736
|
|
|
$
|
(378
|
)
|
|
14
|
|
$
|
581,440
|
|
|
$
|
(1,793
|
)
|
|
28
|
Non-Agency MBS
|
14,490
|
|
|
(140
|
)
|
|
4
|
|
70,876
|
|
|
(581
|
)
|
|
22
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Continuous unrealized loss position for 12 months or longer:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Agency MBS
|
$
|
294,704
|
|
|
$
|
(2,184
|
)
|
|
9
|
|
$
|
1,543,892
|
|
|
$
|
(54,260
|
)
|
|
88
|
Non-Agency MBS
|
7,117
|
|
|
(51
|
)
|
|
8
|
|
46,154
|
|
|
(747
|
)
|
|
19
|
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||||||||
Collateral Type
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
|
Balance
|
|
Weighted
Average Rate
|
|
Fair Value of
Collateral Pledged
|
||||||||||
Agency RMBS
|
|
$
|
2,938,383
|
|
|
2.65
|
%
|
|
$
|
3,073,151
|
|
|
$
|
1,887,878
|
|
|
2.66
|
%
|
|
$
|
1,998,922
|
|
Agency CMBS
|
|
1,448,977
|
|
|
2.66
|
%
|
|
1,569,019
|
|
|
919,833
|
|
|
2.51
|
%
|
|
986,861
|
|
||||
Agency CMBS IO
|
|
241,552
|
|
|
2.97
|
%
|
|
270,668
|
|
|
253,258
|
|
|
2.96
|
%
|
|
285,247
|
|
||||
Non-Agency CMBS IO
|
|
186,540
|
|
|
3.30
|
%
|
|
219,562
|
|
|
207,015
|
|
|
3.38
|
%
|
|
240,574
|
|
||||
Total repurchase agreements
|
|
$
|
4,815,452
|
|
|
2.69
|
%
|
|
$
|
5,132,400
|
|
|
$
|
3,267,984
|
|
|
2.69
|
%
|
|
$
|
3,511,604
|
|
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||
Remaining Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
|
Balance
|
|
WAVG Original Term to Maturity
|
||||||
Less than 30 days
|
|
$
|
4,175,623
|
|
|
56
|
|
|
$
|
2,319,911
|
|
|
56
|
|
30 to 90 days
|
|
537,763
|
|
|
90
|
|
|
948,073
|
|
|
89
|
|
||
91 to 180 days
|
|
102,066
|
|
|
183
|
|
|
—
|
|
|
—
|
|
||
Total
|
|
$
|
4,815,452
|
|
|
62
|
|
|
$
|
3,267,984
|
|
|
66
|
|
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet (1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
June 30, 2019
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchase agreements
|
$
|
4,815,452
|
|
|
$
|
—
|
|
|
$
|
4,815,452
|
|
|
$
|
(4,815,452
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Repurchase agreements
|
$
|
3,267,984
|
|
|
$
|
—
|
|
|
$
|
3,267,984
|
|
|
$
|
(3,267,984
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of debt securities up to and not exceeding the net amount of the repurchase agreement liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented.
|
Type of Derivative Instrument
|
|
Balance Sheet Location
|
|
Purpose
|
|
June 30, 2019
|
|
December 31, 2018
|
||||
Interest rate swaps (1)
|
|
Derivative assets
|
|
Economic hedging
|
|
$
|
—
|
|
|
$
|
324
|
|
TBA securities
|
|
Derivative assets
|
|
Trading
|
|
342
|
|
|
6,239
|
|
||
|
|
|
|
|
|
$
|
342
|
|
|
$
|
6,563
|
|
|
|
|
|
|
|
|
|
|
||||
Eurodollar futures
|
|
Derivative liabilities
|
|
Economic hedging
|
|
$
|
(102
|
)
|
|
$
|
—
|
|
TBA securities
|
|
Derivative liabilities
|
|
Trading
|
|
(105
|
)
|
|
—
|
|
||
U.S. Treasury futures
|
|
Derivative liabilities
|
|
Economic hedging
|
|
—
|
|
|
(1,218
|
)
|
||
|
|
|
|
|
|
$
|
(207
|
)
|
|
$
|
(1,218
|
)
|
(1)
|
Amounts shown as of June 30, 2019 and December 31, 2018 are net of $(50,907) paid and $8,424 received, respectively, in variation margin which is recorded on the Company’s consolidated balance sheets within “restricted cash”. As of June 30, 2019, all of the Company’s interest rate swap agreements are centrally cleared through the CME. Please refer to Note 1 for information regarding the exchange of variation margin being legally considered as settlement of the derivative as opposed to a pledge of collateral. The amount shown as of December 31, 2018 is the unsettled fair value of the instruments subject to bilateral agreements and not centrally cleared through the CME as of that date.
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
June 30,
|
|
June 30,
|
||||||||||||
Type of Derivative Instrument
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Interest rate swaps
|
|
$
|
(124,213
|
)
|
|
20,571
|
|
|
$
|
(195,978
|
)
|
|
68,814
|
|
||
Eurodollar futures
|
|
(102
|
)
|
|
170
|
|
|
(102
|
)
|
|
2,075
|
|
||||
U.S. Treasury futures
|
|
—
|
|
|
—
|
|
|
(109
|
)
|
|
—
|
|
||||
Options on U.S. Treasury futures
|
|
—
|
|
|
891
|
|
|
—
|
|
|
891
|
|
||||
TBA dollar roll positions
|
|
6,780
|
|
|
(965
|
)
|
|
16,956
|
|
|
(13,052
|
)
|
||||
TBA economic hedges
|
|
—
|
|
|
—
|
|
|
—
|
|
|
293
|
|
||||
(Loss) gain on derivative instruments, net
|
|
$
|
(117,535
|
)
|
|
$
|
20,667
|
|
|
$
|
(179,233
|
)
|
|
$
|
59,021
|
|
|
|
June 30, 2019
|
|||||||
|
|
|
|
Weighted-Average:
|
|||||
Years to Maturity:
|
|
Notional Amount (1)
|
|
Pay Rate (2)
|
|
Life Remaining (in Years)
|
|||
< 3 years
|
|
$
|
1,150,000
|
|
|
1.76
|
%
|
|
1.3
|
>3 and < 6 years
|
|
910,000
|
|
|
2.15
|
%
|
|
3.5
|
|
>6 and < 10 years
|
|
1,320,000
|
|
|
2.14
|
%
|
|
9.5
|
|
>10 years
|
|
120,000
|
|
|
2.84
|
%
|
|
28.2
|
|
Total
|
|
$
|
3,500,000
|
|
|
2.04
|
%
|
|
5.9
|
|
|
|
|
|
|
|
|||
|
|
December 31, 2018
|
|||||||
|
|
|
|
Weighted-Average:
|
|||||
Years to Maturity:
|
|
Notional Amount (1)
|
|
Pay Rate (2)
|
|
Life Remaining (in Years)
|
|||
< 3 years
|
|
$
|
1,560,000
|
|
|
1.96
|
%
|
|
1.4
|
>3 and < 6 years
|
|
1,230,000
|
|
|
2.23
|
%
|
|
4.4
|
|
>6 and < 10 years
|
|
1,505,000
|
|
|
2.80
|
%
|
|
8.3
|
|
>10 years
|
|
220,000
|
|
|
2.81
|
%
|
|
21.9
|
|
Total
|
|
$
|
4,515,000
|
|
|
2.35
|
%
|
|
5.5
|
(1)
|
The notional amounts include $0 and $775,000 of forward starting pay-fixed interest rate swaps as of June 30, 2019 and December 31, 2018, respectively.
|
(2)
|
Excluding forward starting pay-fixed interest rate swaps, the weighted average pay rate was 2.04% and 2.29% as of June 30, 2019 and December 31, 2018, respectively.
|
|
June 30, 2019
|
|
December 31, 2018
|
||||
Implied market value (1)
|
$
|
374,688
|
|
|
$
|
888,469
|
|
Implied cost basis (2)
|
374,451
|
|
|
882,230
|
|
||
Net carrying value (3)
|
$
|
237
|
|
|
$
|
6,239
|
|
(1)
|
Implied market value represents the estimated fair value of the underlying Agency MBS as if settled as of the date indicated.
|
(2)
|
Implied cost basis represents the forward price to be paid for the underlying Agency MBS as if settled as of the date indicated.
|
(3)
|
Net carrying value is the amount included on the consolidated balance sheets within “derivative assets (liabilities)” and represents the difference between the implied market value and the implied cost basis of the TBA security as of the date indicated.
|
Type of Derivative Instrument
|
|
Notional Amount as of December 31, 2018
|
|
Additions
|
|
Settlements,
Terminations,
or Pair-Offs
|
|
Notional Amount as of June 30, 2019
|
||||||||
Interest rate swaps
|
|
$
|
4,515,000
|
|
|
$
|
2,955,000
|
|
|
$
|
(3,970,000
|
)
|
|
$
|
3,500,000
|
|
Eurodollar futures
|
|
—
|
|
|
3,000,000
|
|
|
—
|
|
|
3,000,000
|
|
||||
TBA dollar roll positions
|
|
860,000
|
|
|
4,830,000
|
|
|
(5,320,000
|
)
|
|
370,000
|
|
||||
U.S. Treasury futures
|
|
50,000
|
|
|
—
|
|
|
(50,000
|
)
|
|
—
|
|
|
Offsetting of Assets
|
||||||||||||||||||||||
|
Gross Amount of Recognized Assets
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Assets Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet (1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Received as Collateral
|
|
Cash Received as Collateral
|
|||||||||||||||||||||
June 30, 2019
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
TBA securities
|
342
|
|
|
—
|
|
|
342
|
|
|
—
|
|
|
—
|
|
|
342
|
|
||||||
Derivative assets
|
$
|
342
|
|
|
$
|
—
|
|
|
$
|
342
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
342
|
|
December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swaps
|
$
|
324
|
|
|
$
|
—
|
|
|
$
|
324
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
324
|
|
TBA securities
|
6,239
|
|
|
—
|
|
|
6,239
|
|
|
—
|
|
|
(1,719
|
)
|
|
4,520
|
|
||||||
Derivative assets
|
$
|
6,563
|
|
|
$
|
—
|
|
|
$
|
6,563
|
|
|
$
|
—
|
|
|
$
|
(1,719
|
)
|
|
$
|
4,844
|
|
|
Offsetting of Liabilities
|
||||||||||||||||||||||
|
Gross Amount of Recognized Liabilities
|
|
Gross Amount Offset in the Balance Sheet
|
|
Net Amount of Liabilities Presented in the Balance Sheet
|
|
Gross Amount Not Offset in the Balance Sheet (1)
|
|
Net Amount
|
||||||||||||||
Financial Instruments Posted as Collateral
|
|
Cash Posted as Collateral
|
|||||||||||||||||||||
June 30, 2019
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
TBA securities
|
105
|
|
|
—
|
|
|
105
|
|
|
—
|
|
|
(47
|
)
|
|
58
|
|
||||||
Eurodollar Futures
|
102
|
|
|
—
|
|
|
102
|
|
|
—
|
|
|
—
|
|
|
102
|
|
||||||
Derivative liabilities
|
$
|
207
|
|
|
$
|
—
|
|
|
$
|
207
|
|
|
$
|
—
|
|
|
$
|
(47
|
)
|
|
$
|
160
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
U.S. Treasury futures
|
1,218
|
|
|
—
|
|
|
1,218
|
|
|
—
|
|
|
(1,218
|
)
|
|
—
|
|
||||||
Derivative liabilities
|
$
|
1,218
|
|
|
$
|
—
|
|
|
$
|
1,218
|
|
|
$
|
—
|
|
|
$
|
(1,218
|
)
|
|
$
|
—
|
|
(1)
|
Amounts disclosed for collateral received by or posted to the same counterparty include cash and the fair value of MBS up to and not exceeding the net amount of the derivative asset or liability presented in the balance sheet. The fair value of the total collateral received by or posted to the same counterparty may exceed the amounts presented. Please refer to the consolidated balance sheets for the total cash posted as collateral, which is recorded as "restricted cash", and the total fair value of financial instruments pledged as collateral for derivatives and repurchase agreements, which is shown parenthetically.
|
•
|
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
|
•
|
Level 2 – Inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs either directly observable or indirectly observable through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.
|
•
|
Level 3 – Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best estimate of how market participants would price the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||||||||||||||||||
|
Fair Value
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||||||||||
Assets carried at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
MBS
|
$
|
5,713,788
|
|
|
$
|
—
|
|
|
$
|
5,711,894
|
|
|
$
|
1,894
|
|
|
$
|
3,749,464
|
|
|
$
|
—
|
|
|
$
|
3,747,190
|
|
|
$
|
2,274
|
|
Derivative assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Interest rate swaps
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
324
|
|
|
—
|
|
|
324
|
|
|
—
|
|
||||||||
TBA securities
|
342
|
|
|
—
|
|
|
342
|
|
|
—
|
|
|
6,239
|
|
|
—
|
|
|
6,239
|
|
|
—
|
|
||||||||
Total assets carried at fair value
|
$
|
5,714,130
|
|
|
$
|
—
|
|
|
$
|
5,712,236
|
|
|
$
|
1,894
|
|
|
$
|
3,756,027
|
|
|
$
|
—
|
|
|
$
|
3,753,753
|
|
|
$
|
2,274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Liabilities carried at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Eurodollar futures
|
$
|
102
|
|
|
$
|
—
|
|
|
$
|
102
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
TBA securities
|
105
|
|
|
—
|
|
|
105
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
U.S. Treasury futures
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,218
|
|
|
1,218
|
|
|
—
|
|
|
—
|
|
||||||||
Total liabilities carried at fair value
|
$
|
207
|
|
|
$
|
—
|
|
|
$
|
207
|
|
|
$
|
—
|
|
|
$
|
1,218
|
|
|
$
|
1,218
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Six Months Ended
|
||||||
|
June 30,
|
||||||
|
2019
|
|
2018
|
||||
Balance as of beginning of period
|
$
|
2,274
|
|
|
$
|
7,243
|
|
Unrealized gain included in OCI
|
289
|
|
|
(582
|
)
|
||
Principal payments
|
(1,730
|
)
|
|
(692
|
)
|
||
Accretion
|
1,061
|
|
|
604
|
|
||
Balance as of end of period
|
$
|
1,894
|
|
|
$
|
6,573
|
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
||||||||
Assets:
|
|
|
|
|
|
|
|
||||||||
Mortgage-backed securities
|
$
|
5,713,788
|
|
|
$
|
5,713,788
|
|
|
$
|
3,749,464
|
|
|
$
|
3,749,464
|
|
Mortgage loans held for investment, net (1)
|
10,306
|
|
|
7,465
|
|
|
11,527
|
|
|
8,566
|
|
||||
Derivative assets
|
342
|
|
|
342
|
|
|
6,563
|
|
|
6,563
|
|
||||
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Repurchase agreements (2)
|
$
|
4,815,452
|
|
|
$
|
4,815,452
|
|
|
$
|
3,267,984
|
|
|
$
|
3,267,984
|
|
Non-recourse collateralized financing (1)
|
3,078
|
|
|
3,114
|
|
|
3,458
|
|
|
3,475
|
|
||||
Derivative liabilities
|
207
|
|
|
207
|
|
|
1,218
|
|
|
1,218
|
|
(1)
|
The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.
|
(2)
|
The carrying value of repurchase agreements generally approximates fair value due to their short-term maturities.
|
|
|
Six Months Ended
|
||||||
|
|
June 30, 2019
|
||||||
Declaration Date
|
|
Amount Declared (1)
|
|
Record Date
|
|
Payment Date
|
||
January 7, 2019
|
|
$
|
0.18
|
|
|
January 18, 2019
|
|
January 31, 2019
|
January 28, 2019
|
|
0.18
|
|
|
February 14, 2019
|
|
February 28, 2019
|
|
March 12, 2019
|
|
0.18
|
|
|
March 22, 2019
|
|
April 1, 2019
|
|
April 10, 2019
|
|
0.18
|
|
|
April 22, 2019
|
|
May 1, 2019
|
|
May 16, 2019
|
|
0.18
|
|
|
May 28, 2019
|
|
June 7, 2019
|
|
June 6, 2019
|
|
0.18
|
|
|
June 26, 2019
|
|
July 3, 2019
|
1)
|
Amounts declared have been adjusted to reflect the effect of the 1-for-3 reverse stock split.
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
||||||||||||
|
2019
|
|
2018
|
||||||||||
|
Shares (1)
|
|
Weighted Average Grant Date Fair Value Per Share (1)
|
|
Shares (1)
|
|
Weighted Average Grant Date Fair Value Per Share (1)
|
||||||
Restricted stock outstanding as of beginning of period (2)
|
113,904
|
|
|
$
|
19.19
|
|
|
117,701
|
|
|
$
|
21.02
|
|
Restricted stock granted
|
67,997
|
|
|
18.09
|
|
|
71,051
|
|
|
18.95
|
|
||
Restricted stock vested (2)
|
(62,688
|
)
|
|
19.20
|
|
|
(74,849
|
)
|
|
21.85
|
|
||
Restricted stock outstanding as of end of period (2)
|
119,213
|
|
|
$
|
18.56
|
|
|
113,904
|
|
|
$
|
19.19
|
|
(1)
|
Amounts have been adjusted to reflect the effect of the 1-for-3 reverse stock split.
|
(2)
|
Amounts include awards previously granted under the 2009 Plan which will remain outstanding in accordance with their terms. The Company is no longer granting new equity awards under the 2009 Plan.
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
|
|
Agency MBS (1)
|
|
CMBS IO (2)
|
||||||||||||||
Quarter Ended
|
|
Yield
|
|
Cost (3)
|
|
Net Interest Spread
|
|
Yield
|
|
Cost (3)
|
|
Net Interest Spread
|
||||||
June 30, 2019
|
|
3.36
|
%
|
|
2.62
|
%
|
|
0.74
|
%
|
|
3.78
|
%
|
|
3.17
|
%
|
|
0.61
|
%
|
March 31, 2019
|
|
3.42
|
%
|
|
2.62
|
%
|
|
0.80
|
%
|
|
4.04
|
%
|
|
3.20
|
%
|
|
0.84
|
%
|
December 31, 2018
|
|
3.28
|
%
|
|
2.41
|
%
|
|
0.87
|
%
|
|
3.89
|
%
|
|
2.99
|
%
|
|
0.90
|
%
|
September 30, 2018
|
|
3.12
|
%
|
|
2.13
|
%
|
|
0.99
|
%
|
|
3.98
|
%
|
|
2.76
|
%
|
|
1.22
|
%
|
June 30, 2018
|
|
2.94
|
%
|
|
1.93
|
%
|
|
1.01
|
%
|
|
3.78
|
%
|
|
2.59
|
%
|
|
1.19
|
%
|
(1)
|
Includes Agency RMBS and CMBS.
|
(2)
|
Includes Agency and non-Agency issued securities
|
(3)
|
Excludes net periodic interest benefit/cost of interest rate swaps used to economically hedge the interest rate risk of using repurchase agreement borrowings to finance our investments.
|
|
Three Months Ended
|
||||||
($ in thousands, except per share amounts)
|
June 30, 2019
|
|
March 31, 2019
|
||||
GAAP net loss to common shareholders
|
$
|
(122,191
|
)
|
|
$
|
(55,273
|
)
|
Less:
|
|
|
|
||||
Change in fair value of derivative instruments, net (1)
|
122,370
|
|
|
67,557
|
|
||
Loss on sale of investments, net
|
10,360
|
|
|
—
|
|
||
De-designated cash flow hedge accretion (2)
|
—
|
|
|
(165
|
)
|
||
Fair value adjustments, net
|
16
|
|
|
13
|
|
||
Core net operating income to common shareholders
|
$
|
10,555
|
|
|
$
|
12,132
|
|
|
|
|
|
||||
Weighted average common shares outstanding
|
24,541,059
|
|
|
22,811,570
|
|
||
Core net operating income per common share
|
$
|
0.43
|
|
|
$
|
0.53
|
|
(1)
|
Amount represents net realized and unrealized gains and losses on derivatives and excludes net periodic interest benefits related to these instruments.
|
(2)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
Three Months Ended
|
||||||||||||
|
June 30, 2019
|
|
March 31, 2019
|
||||||||||
($ in thousands)
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
Net interest income
|
$
|
12,935
|
|
|
0.76
|
%
|
|
$
|
13,681
|
|
|
0.84
|
%
|
Add: TBA drop income (1)
|
1,282
|
|
|
(0.04
|
)%
|
|
1,963
|
|
|
(0.03
|
)%
|
||
Add: net periodic interest benefit (2)
|
3,553
|
|
|
0.31
|
%
|
|
3,897
|
|
|
0.40
|
%
|
||
Less: de-designated cash flow hedge accretion (3)
|
—
|
|
|
—
|
%
|
|
(165
|
)
|
|
(0.02
|
)%
|
||
Adjusted net interest income
|
$
|
17,770
|
|
|
1.03
|
%
|
|
$
|
19,376
|
|
|
1.19
|
%
|
(1)
|
TBA drop income is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates. The impact of TBA drop income on adjusted net interest spread includes the implied average funding cost of TBA dollar roll transactions during the periods indicated.
|
(2)
|
Amount represents net periodic interest benefit of effective interest rate swaps outstanding during the period and excludes realized and unrealized gains and losses from changes in fair value of derivatives.
|
(3)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||
($ in thousands)
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
Agency RMBS, fixed-rate
|
$
|
3,150,337
|
|
|
$
|
3,205,640
|
|
|
$
|
2,142,717
|
|
|
$
|
2,124,810
|
|
TBAs, fixed-rate (1)
|
374,451
|
|
|
374,688
|
|
|
882,230
|
|
|
888,469
|
|
||||
Agency RMBS, adjustable rate
|
27,106
|
|
|
27,664
|
|
|
32,666
|
|
|
33,211
|
|
||||
Agency CMBS, fixed-rate
|
1,890,910
|
|
|
1,982,635
|
|
|
1,080,424
|
|
|
1,057,015
|
|
||||
CMBS IO (2)
|
482,431
|
|
|
495,956
|
|
|
527,743
|
|
|
532,154
|
|
||||
Non-Agency other (3)
|
1,189
|
|
|
1,894
|
|
|
1,859
|
|
|
2,274
|
|
||||
Mortgage loans held for investment, net (4)
|
10,306
|
|
|
7,465
|
|
|
11,527
|
|
|
8,566
|
|
||||
Total investment portfolio including TBA dollar roll positions
|
$
|
5,936,730
|
|
|
$
|
6,095,942
|
|
|
$
|
4,679,166
|
|
|
$
|
4,646,499
|
|
(1)
|
Consists of long positions in TBAs used for investment purposes at their implied cost basis and implied market value, respectively, as if settled which are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.
|
(2)
|
Includes Agency and non-Agency issued securities.
|
(3)
|
Includes non-Agency CMBS and RMBS.
|
(4)
|
Recorded on consolidated balance sheet at amortized cost.
|
|
Agency Fixed-Rate
|
|
CMBS IO (3)
|
|
Agency Adjustable Rate RMBS
|
|
Non-Agency Other (4)
|
|
Total
|
||||||||||||||
($ in thousands)
|
30-Year RMBS (1) (2)
|
|
CMBS
|
|
|
|
|
||||||||||||||||
Balance as of December 31, 2018
|
$
|
3,013,279
|
|
|
$
|
1,057,015
|
|
|
$
|
532,154
|
|
|
$
|
33,211
|
|
|
$
|
2,274
|
|
|
$
|
4,637,933
|
|
Purchases
|
854,368
|
|
|
1,079,137
|
|
|
26,411
|
|
|
—
|
|
|
—
|
|
|
1,959,916
|
|
||||||
Principal payments
|
(139,910
|
)
|
|
(47,973
|
)
|
|
—
|
|
|
(5,366
|
)
|
|
(1,730
|
)
|
|
(194,979
|
)
|
||||||
Sales
|
(209,446
|
)
|
|
(219,691
|
)
|
|
(13,775
|
)
|
|
—
|
|
|
—
|
|
|
(442,912
|
)
|
||||||
(Amortization) accretion
|
(5,171
|
)
|
|
(987
|
)
|
|
(57,948
|
)
|
|
(193
|
)
|
|
1,061
|
|
|
(63,238
|
)
|
||||||
Change in fair value
|
67,208
|
|
|
115,134
|
|
|
9,114
|
|
|
12
|
|
|
289
|
|
|
191,757
|
|
||||||
Balance as of June 30, 2019
|
$
|
3,580,328
|
|
|
$
|
1,982,635
|
|
|
$
|
495,956
|
|
|
$
|
27,664
|
|
|
$
|
1,894
|
|
|
$
|
6,088,477
|
|
(1)
|
Includes securities pending settlement as of dates indicated.
|
(2)
|
Includes long positions in TBAs used for investment purposes at their implied market value as if settled which are accounted for as “derivative assets (liabilities)” on our consolidated balance sheet.
|
(3)
|
Includes Agency and non-Agency issued securities.
|
(4)
|
Includes non-Agency CMBS and RMBS.
|
|
|
June 30, 2019
|
|||||||||||||||||||||||
|
|
Par
|
|
Amortized Cost/
Implied Cost
Basis (1)(3)
|
|
Fair
Value (2)(3)
|
|
Weighted Average
|
|||||||||||||||||
Coupon
|
|
|
|
|
Original Loan
Balance (4)
|
|
Loan Age
(in months) (4)
|
|
3 Month
CPR (4)(5)
|
|
Estimated Duration (6)
|
||||||||||||||
|
|
($ in thousands)
|
|
|
|
|
|
|
|||||||||||||||||
30-year fixed-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.0%
|
|
$
|
213,194
|
|
|
$
|
214,671
|
|
|
$
|
216,537
|
|
|
$
|
234,698
|
|
|
32
|
|
|
8.3
|
%
|
|
3.93
|
|
3.5%
|
|
511,703
|
|
|
521,488
|
|
|
528,583
|
|
|
181,439
|
|
|
6
|
|
|
2.7
|
%
|
|
2.37
|
|
||||
4.0%
|
|
1,659,795
|
|
|
1,702,100
|
|
|
1,737,797
|
|
|
257,983
|
|
|
15
|
|
|
10.1
|
%
|
|
1.61
|
|
||||
4.5%
|
|
684,300
|
|
|
712,077
|
|
|
722,723
|
|
|
257,397
|
|
|
7
|
|
|
12.8
|
%
|
|
0.64
|
|
||||
TBA 3.0%
|
|
245,000
|
|
|
246,990
|
|
|
246,885
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
3.37
|
|
||||
TBA 3.5%
|
|
125,000
|
|
|
127,461
|
|
|
127,803
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
1.76
|
|
||||
Total 30-year fixed-rate
|
|
$
|
3,438,992
|
|
|
$
|
3,524,787
|
|
|
$
|
3,580,328
|
|
|
243,472
|
|
|
13
|
|
|
9.4
|
%
|
|
1.80
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjustable-rate (7):
|
|
$
|
26,415
|
|
|
$
|
27,106
|
|
|
$
|
27,664
|
|
|
$
|
207,816
|
|
|
139
|
|
|
24.1
|
%
|
|
0.82
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Agency RMBS (including TBA dollar roll positions)
|
|
$
|
3,465,407
|
|
|
$
|
3,551,893
|
|
|
$
|
3,607,992
|
|
|
$
|
243,168
|
|
|
14
|
|
|
9.5
|
%
|
|
1.79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
December 31, 2018
|
|||||||||||||||||||||||
|
|
Par
|
|
Amortized Cost/
Implied Cost Basis (1)(3)
|
|
Fair
Value (2)(3)
|
|
Weighted Average
|
|||||||||||||||||
Coupon
|
|
|
|
|
Original Loan
Balance (4)
|
|
Loan Age
(in months)
(4)
|
|
3 Month
CPR (4)(5)
|
|
Estimated Duration (6)
|
||||||||||||||
|
|
($ in thousands)
|
|
|
|
|
|
|
|||||||||||||||||
30-year fixed-rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
3.0%
|
|
$
|
223,573
|
|
|
$
|
225,148
|
|
|
$
|
218,286
|
|
|
$
|
233,855
|
|
|
26
|
|
|
5.7
|
%
|
|
5.66
|
|
4.0%
|
|
1,651,854
|
|
|
1,699,012
|
|
|
1,687,390
|
|
|
272,159
|
|
|
10
|
|
|
5.2
|
%
|
|
4.06
|
|
||||
4.5%
|
|
211,429
|
|
|
218,557
|
|
|
219,134
|
|
|
291,874
|
|
|
5
|
|
|
5.3
|
%
|
|
2.48
|
|
||||
TBA 4.0%
|
|
110,000
|
|
|
111,175
|
|
|
112,101
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
3.54
|
|
||||
TBA 4.5%
|
|
750,000
|
|
|
771,055
|
|
|
776,368
|
|
|
n/a
|
|
|
n/a
|
|
|
n/a
|
|
|
2.61
|
|
||||
Total 30-year fixed-rate
|
|
$
|
2,946,856
|
|
|
$
|
3,024,947
|
|
|
$
|
3,013,279
|
|
|
$
|
270,053
|
|
|
11
|
|
|
5.3
|
%
|
|
3.67
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjustable-rate (7):
|
|
$
|
31,782
|
|
|
$
|
32,666
|
|
|
$
|
33,211
|
|
|
$
|
210,597
|
|
|
132
|
|
|
25.6
|
%
|
|
0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total Agency RMBS (including TBA dollar roll positions)
|
|
$
|
2,978,638
|
|
|
$
|
3,057,613
|
|
|
$
|
3,046,490
|
|
|
$
|
269,161
|
|
|
13
|
|
|
5.6
|
%
|
|
3.63
|
|
(1)
|
Implied cost basis of TBA dollar roll positions represents the forward price to be paid for the underlying Agency MBS as if settled.
|
(2)
|
Fair value of TBA dollar roll positions is the implied market value of the underlying Agency security as of the end of the period if settled.
|
(3)
|
The net carrying value of TBA dollar roll positions, which is the difference between their implied market value and implied cost basis, was $0.2 million as of June 30, 2019 and $6.2 million as of December 31, 2018 and is included on the consolidated balance sheet within “derivative assets”.
|
(4)
|
TBA dollar roll positions are excluded from this calculation as they do not have a defined weighted-average loan balance or age until mortgages have been assigned to the pool.
|
(5)
|
Constant prepayment rate (“CPR”) represents the 3-month CPR of Agency RMBS held as of date indicated. Securities with no prepayment history are excluded from this calculation.
|
(6)
|
Duration measures the sensitivity of a security's price to the change in interest rates and represents the percent change in price of a security for a 100-basis point increase in interest rates. We calculate duration using third-party financial models and empirical data. Different models and methodologies can produce different estimates of duration for the same securities.
|
(7)
|
Weighted average coupon based on amortized cost was 4.7% as of June 30, 2019 and 4.3% as of December 31, 2018.
|
|
June 30, 2019
|
|
December 31, 2018
|
|||||||||||||||||||||||
($ in thousands)
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity (1)
|
|
WAC (2)
|
|
Par Value
|
|
Amortized Cost
|
|
Months to Estimated Maturity (1)
|
|
WAC (2)
|
|||||||||||
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Prior to 2009
|
$
|
16,929
|
|
|
$
|
16,471
|
|
|
30
|
|
5.56
|
%
|
|
$
|
20,302
|
|
|
$
|
18,868
|
|
|
33
|
|
5.72
|
%
|
|
2009 to 2012
|
31,557
|
|
|
32,800
|
|
|
38
|
|
4.95
|
%
|
|
74,935
|
|
|
76,567
|
|
|
23
|
|
4.98
|
%
|
|||||
2013 to 2014
|
13,389
|
|
|
13,638
|
|
|
67
|
|
3.61
|
%
|
|
13,516
|
|
|
13,790
|
|
|
73
|
|
3.61
|
%
|
|||||
2015
|
209,838
|
|
|
211,805
|
|
|
90
|
|
2.85
|
%
|
|
210,679
|
|
|
212,755
|
|
|
97
|
|
2.85
|
%
|
|||||
2016
|
20,107
|
|
|
19,931
|
|
|
116
|
|
2.62
|
%
|
|
238,559
|
|
|
240,033
|
|
|
98
|
|
2.43
|
%
|
|||||
2017
|
341,937
|
|
|
343,599
|
|
|
105
|
|
3.07
|
%
|
|
280,530
|
|
|
283,567
|
|
|
106
|
|
3.06
|
%
|
|||||
2018
|
330,578
|
|
|
330,415
|
|
|
134
|
|
3.68
|
%
|
|
236,425
|
|
|
235,847
|
|
|
142
|
|
3.76
|
%
|
|||||
2019 (3)
|
615,479
|
|
|
623,003
|
|
|
135
|
|
3.44
|
%
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
%
|
||||
|
$
|
1,579,814
|
|
|
$
|
1,591,662
|
|
|
118
|
|
3.37
|
%
|
|
$
|
1,074,946
|
|
|
$
|
1,081,427
|
|
|
102
|
|
3.22
|
%
|
(1)
|
Months to estimated maturity is an average weighted by the amortized cost of the investment.
|
(2)
|
The weighted average coupon (“WAC”) is the gross interest rate of the security weighted by the outstanding principal balance.
|
(3)
|
Excludes securities pending settlement with a par value of $296.7 million and amortized cost of $299.7 million as of June 30, 2019.
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||||||||
($ in thousands)
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL (1)
|
|
Amortized Cost
|
|
Fair Value
|
|
Remaining WAL (1)
|
||||||||||
Year of Origination:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
2010-2012
|
$
|
47,664
|
|
|
$
|
48,977
|
|
|
22
|
|
|
$
|
59,593
|
|
|
$
|
60,763
|
|
|
17
|
|
2013
|
62,763
|
|
|
64,249
|
|
|
20
|
|
|
72,649
|
|
|
73,073
|
|
|
22
|
|
||||
2014
|
119,394
|
|
|
122,167
|
|
|
27
|
|
|
134,114
|
|
|
134,808
|
|
|
30
|
|
||||
2015
|
126,590
|
|
|
131,139
|
|
|
32
|
|
|
143,163
|
|
|
144,673
|
|
|
35
|
|
||||
2016
|
52,257
|
|
|
53,785
|
|
|
38
|
|
|
67,625
|
|
|
68,015
|
|
|
41
|
|
||||
2017
|
45,315
|
|
|
46,754
|
|
|
46
|
|
|
46,125
|
|
|
46,336
|
|
|
48
|
|
||||
2018
|
4,336
|
|
|
4,474
|
|
|
69
|
|
|
4,474
|
|
|
4,486
|
|
|
73
|
|
||||
2019
|
24,112
|
|
|
24,411
|
|
|
61
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
$
|
482,431
|
|
|
$
|
495,956
|
|
|
31
|
|
|
$
|
527,743
|
|
|
$
|
532,154
|
|
|
32
|
|
|
For the Six Months Ended
|
|||||||||
|
June 30, 2019
|
|||||||||
|
Common Stock
|
|
APIC
|
|||||||
|
Shares
|
|
Aggregate
Par Value
|
|
||||||
Balance as of December 31, 2018
|
62,817,218
|
|
|
$
|
628
|
|
|
$
|
818,442
|
|
Stock issuance
|
10,884,920
|
|
|
109
|
|
|
63,647
|
|
||
Restricted stock granted, net of amortization
|
204,012
|
|
|
2
|
|
|
591
|
|
||
Adjustments for tax withholding on share-based compensation
|
(48,693
|
)
|
|
(1
|
)
|
|
(295
|
)
|
||
Stock issuance costs
|
—
|
|
|
—
|
|
|
(240
|
)
|
||
1-for-3 reverse stock split (1)
|
(49,210,493
|
)
|
|
(492
|
)
|
|
488
|
|
||
Balance as of June 30, 2019
|
24,646,964
|
|
|
$
|
246
|
|
|
$
|
882,633
|
|
1)
|
Includes fractional shares redeemed for cash.
|
|
Three Months Ended
|
||||||||||||||||||||
|
June 30,
|
||||||||||||||||||||
|
2019
|
|
2018
|
||||||||||||||||||
($ in thousands)
|
Interest Income/Expense
|
|
Average Balance (1)(2)
|
|
Effective Yield/
Cost of Funds (3)(4) |
|
Interest Income/Expense
|
|
Average Balance (1)(2)
|
|
Effective Yield/
Cost of Funds (3)(4) |
||||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Agency RMBS-fixed rate
|
$
|
25,207
|
|
|
$
|
2,920,923
|
|
|
3.45
|
%
|
|
$
|
9,190
|
|
|
$
|
1,135,365
|
|
|
3.24
|
%
|
Agency CMBS-fixed rate
|
11,665
|
|
|
1,463,427
|
|
|
3.15
|
%
|
|
7,267
|
|
|
1,011,945
|
|
|
2.80
|
%
|
||||
Agency RMBS-adjustable rate
|
249
|
|
|
28,593
|
|
|
3.71
|
%
|
|
1,332
|
|
|
254,850
|
|
|
2.14
|
%
|
||||
CMBS IO (5)
|
4,886
|
|
|
492,314
|
|
|
3.78
|
%
|
|
6,298
|
|
|
632,376
|
|
|
3.78
|
%
|
||||
Non-Agency other (6)
|
999
|
|
|
1,489
|
|
|
89.48
|
%
|
|
446
|
|
|
5,022
|
|
|
30.67
|
%
|
||||
U.S. Treasuries
|
—
|
|
|
—
|
|
|
—
|
%
|
|
1,001
|
|
|
156,420
|
|
|
2.57
|
%
|
||||
Other investments (7)
|
742
|
|
|
10,599
|
|
|
4.82
|
%
|
|
388
|
|
|
14,576
|
|
|
3.99
|
%
|
||||
Total:
|
$
|
43,748
|
|
|
$
|
4,917,345
|
|
|
3.43
|
%
|
|
$
|
25,922
|
|
|
$
|
3,210,554
|
|
|
3.13
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Repurchase agreements
|
$
|
30,788
|
|
|
$
|
4,562,992
|
|
|
2.67
|
%
|
|
$
|
14,181
|
|
|
$
|
2,716,097
|
|
|
2.07
|
%
|
Non-recourse collateralized financing
|
25
|
|
|
3,168
|
|
|
2.98
|
%
|
|
42
|
|
|
5,002
|
|
|
2.73
|
%
|
||||
De-designated cash flow hedge accretion (8)
|
—
|
|
|
n/a
|
|
|
—
|
%
|
|
(48
|
)
|
|
n/a
|
|
|
(0.01
|
)%
|
||||
Total:
|
$
|
30,813
|
|
|
$
|
4,566,160
|
|
|
2.67
|
%
|
|
$
|
14,175
|
|
|
$
|
2,721,099
|
|
|
2.06
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Net interest income/net interest spread
|
$
|
12,935
|
|
|
|
|
|
0.76
|
%
|
|
$
|
11,747
|
|
|
|
|
1.07
|
%
|
(1)
|
Average balance for assets is calculated as a simple average of the daily amortized cost and excludes unrealized gains and losses as well as securities pending settlement if applicable.
|
(2)
|
Average balance for liabilities is calculated as a simple average of the daily borrowings outstanding during the period.
|
(3)
|
Effective yield is calculated by dividing the sum of gross interest income and scheduled premium amortization/discount accretion (both of which are annualized for any reporting period less than 12 months) and prepayment compensation and premium amortization/discount accretion adjustments (collectively, "prepayment adjustments"), which are not annualized, by the average balance of asset type outstanding during the reporting period.
|
(4)
|
Cost of funds is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.
|
(5)
|
Includes Agency and non-Agency issued securities.
|
(6)
|
Includes privately-issued RMBS and CMBS.
|
(7)
|
Interest income for other investments consists of $131 thousand from mortgage loans held for investment, net and $611 thousand from cash and cash equivalents for the three months ended June 30, 2019 compared to $143 thousand and $245 thousand for the three months ended June 30, 2018, respectively. Average balances and yields shown for other investments includes amortized cost of mortgage loans held for investment and excludes cash.
|
(8)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
Three Months
|
||||||||||||||
|
June 30, 2019 Compared to June 30, 2018
|
||||||||||||||
|
Increase (Decrease) Due to Change In
|
|
Total Change in Interest Income/Expense
|
||||||||||||
($ in thousands)
|
Rate
|
|
Volume
|
|
Prepayment Adjustments (1)
|
|
|||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
||||||||
Agency RMBS-fixed rate
|
$
|
1,564
|
|
|
$
|
14,453
|
|
|
$
|
—
|
|
|
$
|
16,017
|
|
Agency CMBS-fixed rate
|
1,358
|
|
|
3,182
|
|
|
(143
|
)
|
|
4,397
|
|
||||
Agency RMBS-adjustable rate
|
116
|
|
|
(1,218
|
)
|
|
20
|
|
|
(1,082
|
)
|
||||
CMBS IO (2)
|
6
|
|
|
(1,301
|
)
|
|
(117
|
)
|
|
(1,412
|
)
|
||||
Non-Agency other (3)
|
38
|
|
|
(291
|
)
|
|
806
|
|
|
553
|
|
||||
Treasuries
|
—
|
|
|
(1,001
|
)
|
|
—
|
|
|
(1,001
|
)
|
||||
Other investments (4)
|
22
|
|
|
326
|
|
|
6
|
|
|
354
|
|
||||
Total increase in interest income
|
$
|
3,104
|
|
|
$
|
14,150
|
|
|
$
|
572
|
|
|
$
|
17,826
|
|
|
|
|
|
|
|
|
|
||||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
||||||||
Repurchase agreements
|
$
|
6,964
|
|
|
$
|
9,643
|
|
|
$
|
—
|
|
|
$
|
16,607
|
|
Non-recourse collateralized financing, net of other (5)
|
44
|
|
|
(13
|
)
|
|
—
|
|
|
31
|
|
||||
Total increase in interest expense
|
7,008
|
|
|
9,630
|
|
|
—
|
|
|
16,638
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total net change in net interest income
|
$
|
(3,904
|
)
|
|
$
|
4,520
|
|
|
$
|
572
|
|
|
$
|
1,188
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for adjustable-rate RMBS and prepayment compensation, net of amortization adjustments for CMBS and CMBS IO and are not annualized in the calculation of effective yield.
|
(2)
|
Includes Agency and non-Agency issued securities.
|
(3)
|
Includes privately-issued RMBS and CMBS.
|
(4)
|
Increase of $366 thousand in other interest income from cash and cash equivalents is included as a change in volume.
|
(5)
|
Change in de-designated cash flow hedge accretion of $(48) thousand is included as a change in rate.
|
|
Three Months Ended
|
||||||||||||
|
June 30,
|
||||||||||||
|
2019
|
|
2018
|
||||||||||
($ in thousands)
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
Net interest income
|
$
|
12,935
|
|
|
0.76
|
%
|
|
$
|
11,747
|
|
|
1.07
|
%
|
Add: TBA drop income (1)
|
1,282
|
|
|
(0.04
|
)%
|
|
3,619
|
|
|
0.10
|
%
|
||
Add: net periodic interest benefit (2)
|
3,553
|
|
|
0.31
|
%
|
|
2,333
|
|
|
0.35
|
%
|
||
De-designated cash flow hedge accretion (3)
|
—
|
|
|
—
|
%
|
|
(48
|
)
|
|
(0.01
|
)%
|
||
Adjusted net interest income
|
$
|
17,770
|
|
|
1.03
|
%
|
|
$
|
17,651
|
|
|
1.51
|
%
|
(1)
|
TBA drop income is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates. The impact of TBA drop income on adjusted net interest spread includes the implied average funding cost of TBA dollar roll transactions during the periods indicated.
|
(2)
|
Amount represents net periodic interest benefit of effective interest rate swaps outstanding during the period and excludes realized and unrealized gains and losses from changes in fair value of derivatives.
|
(3)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
Three Months Ended
|
|
Three Months Ended June 30, 2019 Compared to Three Months Ended June 30, 2018
|
||||||||||||||||||||||
|
June 30,
|
|
|||||||||||||||||||||||
|
2019
|
|
2018
|
|
Total Change
|
|
Due to Change In
|
||||||||||||||||||
($ in thousands)
|
Amount
|
|
Average Yield/Cost
|
|
Amount
|
|
Average Yield/Cost
|
|
|
Rate
|
|
Volume
|
|||||||||||||
TBA implied interest income (1)
|
$
|
5,692
|
|
|
3.34
|
%
|
|
$
|
6,771
|
|
|
3.61
|
%
|
|
$
|
(1,079
|
)
|
|
$
|
(448
|
)
|
|
$
|
(631
|
)
|
TBA implied interest expense (2)
|
4,410
|
|
|
2.59
|
%
|
|
3,152
|
|
|
1.68
|
%
|
|
1,258
|
|
|
1,552
|
|
|
(294
|
)
|
|||||
TBA drop income/net yield (3)
|
$
|
1,282
|
|
|
0.75
|
%
|
|
$
|
3,619
|
|
|
1.93
|
%
|
|
$
|
(2,337
|
)
|
|
$
|
(2,000
|
)
|
|
$
|
(337
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Average dollar roll position
|
$
|
672,973
|
|
|
|
|
$
|
742,111
|
|
|
|
|
|
|
|
|
|
(1)
|
Average yield for TBA dollar roll positions is extrapolated by adding average cost (see footnote 2) to the net yield (see footnote 3). Implied interest income is calculated by multiplying the average yield by the average TBA dollar roll position outstanding during the period.
|
(2)
|
Average funding cost for TBA dollar roll positions is determined using the “price drop” between the near settling TBA contract and the price for the same contract with a later settlement date and market-based assumptions regarding the “cheapest-to-deliver” collateral that can satisfy the TBA contract, such as the security’s coupon, maturity, and projected prepayment rate
|
(3)
|
TBA net yield is calculated by dividing drop income by the average TBA dollar roll position outstanding during the period.
|
|
Six Months Ended
|
||||||||||||||||||||
|
June 30,
|
||||||||||||||||||||
|
2019
|
|
2018
|
||||||||||||||||||
($ in thousands)
|
Interest Income/Expense
|
|
Average Balance (1)(2)
|
|
Effective Yield/
Cost of Funds (3)(4) |
|
Interest Income/Expense
|
|
Average Balance (1)(2)
|
|
Effective Yield/
Cost of Funds (3)(4) |
||||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Agency RMBS-fixed rate
|
$
|
48,618
|
|
|
$
|
2,763,980
|
|
|
3.52
|
%
|
|
$
|
16,292
|
|
|
$
|
1,019,891
|
|
|
3.19
|
%
|
Agency CMBS-fixed rate
|
20,797
|
|
|
1,332,700
|
|
|
3.10
|
%
|
|
14,895
|
|
|
1,046,882
|
|
|
2.81
|
%
|
||||
Agency RMBS-adjustable rate
|
472
|
|
|
30,037
|
|
|
3.40
|
%
|
|
2,921
|
|
|
268,733
|
|
|
2.15
|
%
|
||||
CMBS IO (5)
|
11,282
|
|
|
505,020
|
|
|
4.10
|
%
|
|
13,240
|
|
|
650,799
|
|
|
3.90
|
%
|
||||
Non-Agency other (6)
|
1,176
|
|
|
1,655
|
|
|
86.39
|
%
|
|
1,069
|
|
|
11,792
|
|
|
16.39
|
%
|
||||
U.S. Treasuries
|
—
|
|
|
—
|
|
|
—
|
%
|
|
1,967
|
|
|
162,431
|
|
|
2.44
|
%
|
||||
Other investments (7)
|
1,361
|
|
|
10,916
|
|
|
4.90
|
%
|
|
728
|
|
|
15,007
|
|
|
4.04
|
%
|
||||
Total:
|
$
|
83,706
|
|
|
$
|
4,644,308
|
|
|
3.49
|
%
|
|
$
|
51,112
|
|
|
$
|
3,175,535
|
|
|
3.14
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Repurchase agreements
|
$
|
57,202
|
|
|
$
|
4,248,909
|
|
|
2.68
|
%
|
|
$
|
25,795
|
|
|
$
|
2,681,100
|
|
|
1.91
|
%
|
Non-recourse collateralized financing
|
52
|
|
|
3,281
|
|
|
3.15
|
%
|
|
71
|
|
|
5,193
|
|
|
2.53
|
%
|
||||
De-designated cash flow hedge accretion (8)
|
(165
|
)
|
|
n/a
|
|
|
(0.01
|
)%
|
|
(96
|
)
|
|
n/a
|
|
|
(0.01
|
)%
|
||||
Total:
|
$
|
57,089
|
|
|
$
|
4,252,190
|
|
|
2.67
|
%
|
|
$
|
25,770
|
|
|
$
|
2,686,293
|
|
|
1.91
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Net interest income/net interest spread
|
$
|
26,617
|
|
|
|
|
|
0.82
|
%
|
|
$
|
25,342
|
|
|
|
|
1.23
|
%
|
(1)
|
Average balance for assets is calculated as a simple average of the daily amortized cost and excludes unrealized gains and losses as well as securities pending settlement if applicable.
|
(2)
|
Average balance for liabilities is calculated as a simple average of the daily borrowings outstanding during the period.
|
(3)
|
Effective yield is calculated by dividing the sum of gross interest income and scheduled premium amortization/discount accretion (both of which are annualized for any reporting period less than 12 months) and prepayment compensation and premium amortization/discount accretion adjustments (collectively, "prepayment adjustments"), which are not annualized, by the average balance of asset type outstanding during the reporting period.
|
(4)
|
Cost of funds is calculated by dividing annualized interest expense by the total average balance of borrowings outstanding during the period with an assumption of 360 days in a year.
|
(5)
|
Includes Agency and non-Agency issued securities.
|
(6)
|
Includes privately-issued RMBS and CMBS.
|
(7)
|
Interest income for other investments consists of $275 thousand from mortgage loans held for investment, net and $1,087 thousand from cash and cash equivalents for the six months ended June 30, 2019 compared to $305 thousand and $423
|
(8)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
Six Months Ended
|
||||||||||||||
|
June 30, 2019 Compared to June 30, 2018
|
||||||||||||||
|
Increase (Decrease) Due to Change In
|
|
Total Change in Interest Income/Expense
|
||||||||||||
($ in thousands)
|
Rate
|
|
Volume
|
|
Prepayment Adjustments (1)
|
|
|||||||||
Interest-earning assets:
|
|
|
|
|
|
|
|
||||||||
Agency RMBS-fixed rate
|
$
|
4,465
|
|
|
$
|
27,861
|
|
|
$
|
—
|
|
|
$
|
32,326
|
|
Agency CMBS-fixed rate
|
2,088
|
|
|
4,008
|
|
|
(194
|
)
|
|
5,902
|
|
||||
Agency RMBS-adjustable rate
|
230
|
|
|
(2,544
|
)
|
|
(135
|
)
|
|
(2,449
|
)
|
||||
CMBS IO (2)
|
4
|
|
|
(2,716
|
)
|
|
754
|
|
|
(1,958
|
)
|
||||
Non-Agency other (3)
|
162
|
|
|
(771
|
)
|
|
716
|
|
|
107
|
|
||||
Treasuries
|
—
|
|
|
(1,967
|
)
|
|
—
|
|
|
(1,967
|
)
|
||||
Other investments (4)
|
47
|
|
|
581
|
|
|
5
|
|
|
633
|
|
||||
Total increase in interest income
|
$
|
6,996
|
|
|
$
|
24,452
|
|
|
$
|
1,146
|
|
|
$
|
32,594
|
|
|
|
|
|
|
|
|
|
|
|||||||
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|||||||
Repurchase agreements
|
$
|
16,322
|
|
|
$
|
15,085
|
|
|
$
|
—
|
|
|
$
|
31,407
|
|
Non-recourse collateralized financing, net of other (5)
|
(59
|
)
|
|
(24
|
)
|
|
(5
|
)
|
|
(88
|
)
|
||||
Total increase (decrease) in interest expense
|
16,263
|
|
|
15,061
|
|
|
(5
|
)
|
|
31,319
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total net change in net interest income
|
$
|
(9,267
|
)
|
|
$
|
9,391
|
|
|
$
|
1,151
|
|
|
$
|
1,275
|
|
(1)
|
Prepayment adjustments represent effective interest amortization adjustments related to changes in actual and projected prepayment speeds for adjustable-rate RMBS and prepayment compensation, net of amortization adjustments for CMBS and CMBS IO and are not annualized in the calculation of effective yield.
|
(2)
|
Includes Agency and non-Agency issued securities.
|
(3)
|
Includes privately-issued RMBS and CMBS.
|
(4)
|
Increase of $664 thousand in other interest income from cash and cash equivalents is included as a change in volume.
|
(5)
|
Change in de-designated cash flow hedge accretion of $69 thousand is included as a change in rate.
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
||||||||||||
|
2019
|
|
2018
|
||||||||||
($ in thousands)
|
Amount
|
|
Rate
|
|
Amount
|
|
Rate
|
||||||
Net interest income
|
$
|
26,617
|
|
|
0.82
|
%
|
|
$
|
25,342
|
|
|
1.23
|
%
|
Add: TBA drop income (1)
|
3,245
|
|
|
(0.03
|
)%
|
|
7,352
|
|
|
0.09
|
%
|
||
Add: net periodic interest benefit (2)
|
7,450
|
|
|
0.35
|
%
|
|
2,113
|
|
|
0.16
|
%
|
||
De-designated cash flow hedge accretion (3)
|
(165
|
)
|
|
(0.01
|
)%
|
|
(96
|
)
|
|
(0.01
|
)%
|
||
Adjusted net interest income
|
$
|
37,147
|
|
|
1.13
|
%
|
|
$
|
34,711
|
|
|
1.47
|
%
|
(1)
|
TBA drop income is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates. The impact of TBA drop income on adjusted net interest spread includes the implied average funding cost of TBA dollar roll transactions during the periods indicated.
|
(2)
|
Amount represents net periodic interest benefit of effective interest rate swaps outstanding during the period and excludes realized and unrealized gains and losses from changes in fair value of derivatives.
|
(3)
|
Amount recorded as a portion of "interest expense" in accordance with GAAP related to the accretion of the balance remaining in accumulated other comprehensive loss as a result of the Company's discontinuation of cash flow hedge accounting effective June 30, 2013.
|
|
Six Months Ended
|
|
Six Months Ended June 30, 2019 Compared to Six Months Ended June 30, 2018
|
||||||||||||||||||||||
|
June 30,
|
|
|||||||||||||||||||||||
|
2019
|
|
2018
|
|
Total Change
|
|
Due to Change In
|
||||||||||||||||||
($ in thousands)
|
Amount
|
|
Average Yield/Cost
|
|
Amount
|
|
Average Yield/Cost
|
|
|
Rate
|
|
Volume
|
|||||||||||||
TBA implied interest income (1)
|
$
|
12,485
|
|
|
3.55
|
%
|
|
$
|
13,821
|
|
|
3.42
|
%
|
|
$
|
(1,336
|
)
|
|
$
|
472
|
|
|
$
|
(1,791
|
)
|
TBA implied interest expense (2)
|
9,240
|
|
|
2.63
|
%
|
|
6,469
|
|
|
1.60
|
%
|
|
2,771
|
|
|
(3,625
|
)
|
|
837
|
|
|||||
TBA drop income/net yield (3)
|
$
|
3,245
|
|
|
0.92
|
%
|
|
$
|
7,352
|
|
|
1.82
|
%
|
|
$
|
(4,107
|
)
|
|
$
|
(3,153
|
)
|
|
$
|
(954
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Average dollar roll position
|
$
|
699,751
|
|
|
|
|
$
|
804,122
|
|
|
|
|
|
|
|
|
|
(1)
|
Average yield for TBA dollar roll positions is extrapolated by adding average cost (see footnote 2) to the net yield (see footnote 3). Implied interest income is calculated by multiplying the average yield by the average TBA dollar roll position outstanding during the period.
|
(2)
|
Average funding cost for TBA dollar roll positions is determined using the “price drop” between the near settling TBA contract and the price for the same contract with a later settlement date and market-based assumptions regarding the “cheapest-to-
|
(3)
|
TBA net yield is calculated by dividing drop income by the average TBA dollar roll position outstanding during the period.
|
|
Three Months Ended
|
||||||||||||||
|
June 30,
|
||||||||||||||
|
2019
|
|
2018
|
||||||||||||
($ in thousands)
|
Amortized cost basis sold
|
|
Loss on sale of investments, net
|
|
Amortized cost basis sold
|
|
Loss on sale of investments, net
|
||||||||
Agency RMBS
|
$
|
209,446
|
|
|
$
|
(3,953
|
)
|
|
$
|
225,622
|
|
|
$
|
(7,785
|
)
|
Agency CMBS
|
219,691
|
|
|
(6,493
|
)
|
|
—
|
|
|
—
|
|
||||
Agency CMBS IO
|
13,775
|
|
|
86
|
|
|
—
|
|
|
—
|
|
||||
Non-Agency CMBS IO
|
—
|
|
|
—
|
|
|
8,644
|
|
|
51
|
|
||||
U.S. Treasuries
|
—
|
|
|
—
|
|
|
149,171
|
|
|
(4,710
|
)
|
||||
|
$
|
442,912
|
|
|
$
|
(10,360
|
)
|
|
$
|
383,437
|
|
|
$
|
(12,444
|
)
|
|
|
|
|
|
|
|
|
||||||||
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
||||||||||||||
|
2019
|
|
2018
|
||||||||||||
($ in thousands)
|
Amortized cost basis sold
|
|
Loss on sale of investments, net
|
|
Amortized cost basis sold
|
|
Loss on sale of investments, net
|
||||||||
Agency RMBS
|
$
|
209,446
|
|
|
$
|
(3,953
|
)
|
|
$
|
225,622
|
|
|
$
|
(7,785
|
)
|
Agency CMBS
|
219,691
|
|
|
(6,493
|
)
|
|
110,810
|
|
|
(2,052
|
)
|
||||
Agency CMBS IO
|
13,775
|
|
|
86
|
|
|
—
|
|
|
—
|
|
||||
Non-Agency CMBS IO
|
—
|
|
|
—
|
|
|
8,644
|
|
|
51
|
|
||||
U.S. Treasuries
|
—
|
|
|
—
|
|
|
197,393
|
|
|
(6,433
|
)
|
||||
|
$
|
442,912
|
|
|
$
|
(10,360
|
)
|
|
$
|
542,469
|
|
|
$
|
(16,219
|
)
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Interest rate derivatives:
|
|
|
|
|
|
|
|
||||||||
Interest rate swaps:
|
|
|
|
|
|
|
|
||||||||
Net periodic interest benefit (cost)
|
$
|
3,553
|
|
|
$
|
2,333
|
|
|
$
|
7,450
|
|
|
$
|
2,113
|
|
Change in fair value (1)
|
(127,766
|
)
|
|
18,239
|
|
|
(203,428
|
)
|
|
66,702
|
|
||||
Total interest rate swap (losses) gains, net
|
(124,213
|
)
|
|
20,572
|
|
|
(195,978
|
)
|
|
68,815
|
|
||||
U.S. Treasury and Eurodollar futures:
|
|
|
|
|
|
|
|
||||||||
Change in fair value (1)
|
(102
|
)
|
|
170
|
|
|
(211
|
)
|
|
2,075
|
|
||||
TBA short positions (economic hedges):
|
|
|
|
|
|
|
|
||||||||
Change in fair value (2)
|
—
|
|
|
—
|
|
|
—
|
|
|
293
|
|
||||
Total interest rate derivative (losses) gains, net
|
(124,315
|
)
|
|
20,742
|
|
|
(196,189
|
)
|
|
71,183
|
|
||||
|
|
|
|
|
|
|
|
||||||||
TBA dollar roll positions:
|
|
|
|
|
|
|
|
||||||||
Change in fair value (2)
|
5,498
|
|
|
(4,585
|
)
|
|
13,711
|
|
|
(20,405
|
)
|
||||
TBA drop income (3)
|
1,282
|
|
|
3,619
|
|
|
3,245
|
|
|
7,352
|
|
||||
Total TBA dollar roll gains (losses), net
|
6,780
|
|
|
(966
|
)
|
|
16,956
|
|
|
(13,053
|
)
|
||||
|
|
|
|
|
|
|
|
||||||||
Options on U.S. Treasury futures
|
—
|
|
|
891
|
|
|
—
|
|
|
891
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Total (loss) gain on derivative instruments, net
|
$
|
(117,535
|
)
|
|
$
|
20,667
|
|
|
$
|
(179,233
|
)
|
|
$
|
59,021
|
|
(1)
|
Changes in fair value for interest rate swaps, U.S. Treasury, and Eurodollar futures include unrealized gains (losses) from current and forward starting derivative instruments and realized gains (losses) from terminated derivative instruments.
|
(2)
|
Changes in fair value for TBA positions include unrealized gains (losses) from open TBA contracts and realized gains (losses) on paired off or terminated positions.
|
(3)
|
TBA drop income represents a portion of the change in fair value and is calculated by multiplying the notional amount of the TBA dollar roll positions by the difference in price between two TBA securities with the same terms but different settlement dates.
|
(1)
|
Because the Company executes TBA dollar roll transactions, which economically represent the purchase and financing of fixed-rate Agency RMBS, the average TBAs outstanding are included in the ratio calculation.
|
(2)
|
Net rates include receive-fixed (pay-floating) interest rate swaps for the three and six months ended June 30, 2018.
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
($ in thousands)
|
2019
|
|
2018
|
|
2019
|
|
2018
|
||||||||
Fixed-rate Agency RMBS
|
$
|
35,386
|
|
|
$
|
(6,724
|
)
|
|
$
|
73,210
|
|
|
$
|
(24,500
|
)
|
Adjustable-rate Agency RMBS
|
64
|
|
|
6,703
|
|
|
12
|
|
|
4,585
|
|
||||
Agency CMBS
|
70,822
|
|
|
(11,943
|
)
|
|
115,133
|
|
|
(33,305
|
)
|
||||
CMBS IO (1)
|
4,833
|
|
|
26
|
|
|
9,114
|
|
|
(2,957
|
)
|
||||
Non-Agency other (2)
|
22
|
|
|
(272
|
)
|
|
290
|
|
|
(636
|
)
|
||||
U.S. Treasuries
|
—
|
|
|
2,498
|
|
|
—
|
|
|
1,687
|
|
||||
Unrealized gain (loss) on available-for-sale investments
|
111,127
|
|
|
(9,712
|
)
|
|
197,759
|
|
|
(55,126
|
)
|
||||
Reclassification adjustment for de-designated cash flow hedges
|
—
|
|
|
(48
|
)
|
|
(165
|
)
|
|
(96
|
)
|
||||
Total other comprehensive income (loss)
|
$
|
111,127
|
|
|
$
|
(9,760
|
)
|
|
$
|
197,594
|
|
|
$
|
(55,222
|
)
|
(1)
|
Includes Agency and non-Agency issued securities.
|
(2)
|
Includes non-Agency CMBS and RMBS.
|
|
Repurchase Agreements
|
|
TBA Dollar Roll Positions (1)
|
||||||||||||||||
($ in thousands)
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
|
Maximum Balance Outstanding During the Quarter Ended
|
|
Balance Outstanding As of Quarter End
|
|
Average Balance Outstanding For the Quarter Ended
|
||||||||||
June 30, 2019
|
$
|
4,815,452
|
|
|
$
|
4,562,992
|
|
|
$
|
4,815,452
|
|
|
$
|
374,451
|
|
|
$
|
579,353
|
|
March 31, 2019
|
4,252,893
|
|
|
3,931,335
|
|
|
4,266,684
|
|
|
727,212
|
|
|
722,264
|
|
|||||
December 31, 2018
|
3,267,984
|
|
|
2,992,513
|
|
|
3,269,307
|
|
|
882,230
|
|
|
814,478
|
|
|||||
September 30, 2018
|
2,690,858
|
|
|
2,564,863
|
|
|
2,701,797
|
|
|
780,865
|
|
|
982,665
|
|
|||||
June 30, 2018
|
2,514,984
|
|
|
2,716,097
|
|
|
2,844,225
|
|
|
782,408
|
|
|
722,005
|
|
(1)
|
Balance outstanding as of quarter end and average balance outstanding for the quarter ended includes TBA dollar roll positions as reported at cost (as if settled). Does not include short TBA positions used to hedge interest rate risk exposure from fixed-rate Agency RMBS in applicable periods.
|
|
June 30, 2019
|
|
March 31, 2019
|
|
December 31, 2018
|
|
September 30, 2018
|
|
June 30, 2018
|
|||||
Agency CMBS and RMBS
|
4.7
|
%
|
|
4.8
|
%
|
|
4.9
|
%
|
|
4.8
|
%
|
|
4.9
|
%
|
CMBS IO
|
13.2
|
%
|
|
13.4
|
%
|
|
13.4
|
%
|
|
13.3
|
%
|
|
13.3
|
%
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||||
($ in thousands)
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
|
Amount Outstanding
|
|
Market Value of Collateral Pledged
|
||||||||
North America
|
$
|
3,444,707
|
|
|
$
|
3,688,572
|
|
|
$
|
2,190,361
|
|
|
$
|
2,365,132
|
|
Asia
|
696,614
|
|
|
736,161
|
|
|
594,435
|
|
|
633,078
|
|
||||
Europe
|
674,131
|
|
|
707,667
|
|
|
483,188
|
|
|
513,394
|
|
||||
|
$
|
4,815,452
|
|
|
$
|
5,132,400
|
|
|
$
|
3,267,984
|
|
|
$
|
3,511,604
|
|
($ in thousands)
|
|
Payments due by period
|
||||||||||||||||||
Contractual Obligations:
|
|
Total
|
|
< 1 year
|
|
1-3 years
|
|
3-5 years
|
|
> 5 years
|
||||||||||
Repurchase agreements (1)
|
|
$
|
4,822,223
|
|
|
$
|
4,822,223
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Non-recourse collateralized financing (2)
|
|
3,116
|
|
|
985
|
|
|
1,269
|
|
|
666
|
|
|
196
|
|
|||||
Operating lease obligations
|
|
163
|
|
|
163
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
|
$
|
4,825,502
|
|
|
$
|
4,823,371
|
|
|
$
|
1,269
|
|
|
$
|
666
|
|
|
$
|
196
|
|
•
|
Our business and investment strategy including our ability to generate acceptable risk-adjusted returns and our target investment allocations, and our views on the future performance of MBS and other investments;
|
•
|
Our views on conditions in the investment, credit, and derivatives markets;
|
•
|
Our views on the effect of actual or proposed actions of the U.S. Federal Reserve, the FOMC, or other central banks with respect to monetary policy (including the targeted Federal Funds Rate), and the potential impact of these actions on interest rates, inflation or unemployment;
|
•
|
The effect of regulatory initiatives of the Federal Reserve (including the FOMC), other financial regulators, and other central banks;
|
•
|
Our financing strategy including our target leverage ratios, our use of TBA dollar roll transactions, and anticipated trends in financing costs, and our hedging strategy including changes to the derivative instruments to which we are a party, and changes to government regulation of hedging instruments and our use of these instruments;
|
•
|
Our investment portfolio composition and target investments;
|
•
|
Our investment portfolio performance, including the fair value, yields, and forecasted prepayment speeds of our investments;
|
•
|
Our liquidity and ability to access financing, and the anticipated availability and cost of financing;
|
•
|
Our capital stock activity including the impact of stock issuances and repurchases;
|
•
|
The amount, timing, and funding of future dividends;
|
•
|
Our use of and restrictions on using our tax NOL carryforward;
|
•
|
The status of pending litigation;
|
•
|
The competitive environment in the future, including competition for investments and the availability of financing;
|
•
|
Estimates of future interest expenses, including related to the Company’s repurchase agreements and derivative instruments;
|
•
|
The status and effect of legislative reforms and regulatory rule-making or review processes, and the status of reform efforts and other business developments in the repurchase agreement financing market;
|
•
|
Market, industry and economic trends, and how these trends and related economic data may impact the behavior of market participants and financial regulators; and
|
•
|
Market interest rates and market spreads.
|
•
|
the risks and uncertainties referenced in this Quarterly Report on Form 10-Q, particularly those set forth under and incorporated by reference into Part II, Item 1A, “Risk Factors”;
|
•
|
our ability to find suitable reinvestment opportunities;
|
•
|
changes in domestic economic conditions;
|
•
|
changes in interest rates and interest rate spreads, including the repricing of interest-earning assets and interest-bearing liabilities;
|
•
|
our investment portfolio performance particularly as it relates to cash flow, prepayment rates and credit performance;
|
•
|
the impact on markets and asset prices from the Federal Reserve’s balance sheet normalization process through the reduction in its holdings of Agency RMBS and U.S. Treasuries;
|
•
|
actual or anticipated changes in Federal Reserve monetary policy or the monetary policy of other central banks;
|
•
|
adverse reactions in U.S. financial markets related to actions of foreign central banks or the economic performance of foreign economies including in particular China, Japan, the European Union, and the United Kingdom;
|
•
|
uncertainty concerning the long-term fiscal health and stability of the United States;
|
•
|
the cost and availability of financing, including the future availability of financing due to changes to regulation of, and capital requirements imposed upon, financial institutions;
|
•
|
the cost and availability of new equity capital;
|
•
|
changes in our use of leverage;
|
•
|
changes to our investment strategy, operating policies, dividend policy or asset allocations;
|
•
|
the quality of performance of third-party servicer providers of our loans and loans underlying our securities;
|
•
|
the level of defaults by borrowers on loans we have securitized;
|
•
|
changes in our industry;
|
•
|
increased competition;
|
•
|
changes in government regulations affecting our business;
|
•
|
changes or volatility in the repurchase agreement financing markets and other credit markets;
|
•
|
changes to the market for interest rate swaps and other derivative instruments, including changes to margin requirements on derivative instruments;
|
•
|
uncertainty regarding continued government support of the U.S. financial system and U.S. housing and real estate markets; or to reform the U.S. housing finance system including the resolution of the conservatorship of Fannie Mae and Freddie Mac;
|
•
|
the composition of the Board of Governors of the Federal Reserve System;
|
•
|
ownership shifts under Section 382 that further limit the use of our tax NOL carryforward;
|
•
|
systems failures or cybersecurity incidents; and
|
•
|
exposure to current and future claims and litigation.
|
|
Projected Change in Net Interest Income and Net Periodic Interest Benefit/Cost Due To
|
||||||||||
|
Decrease in Interest Rates of
|
|
Increase in Interest Rates of
|
||||||||
|
50 Basis Points
|
|
100 Basis Points
|
|
50 Basis Points
|
|
100 Basis Points
|
||||
June 30, 2019
|
(1.8
|
)%
|
|
(41.1
|
)%
|
|
(9.4
|
)%
|
|
(22.6
|
)%
|
December 31, 2018
|
(8.0
|
)%
|
|
(21.1
|
)%
|
|
4.2
|
%
|
|
6.1
|
%
|
(1)
|
Includes estimated changes in net interest income as well as net periodic interest benefit/cost on our interest rate swaps recorded in “gain (loss) on derivatives instruments, net” and does not include estimated changes to TBA drop income generated by TBA dollar roll transactions, which are accounted for as derivative instruments in accordance with GAAP.
|
|
|
June 30, 2019
|
||||||||||||||||||||||
|
|
Decrease in Interest Rates of
|
|
Increase in Interest Rates of
|
||||||||||||||||||||
|
|
50 Basis Points
|
|
100 Basis Points
|
|
50 Basis Points
|
|
100 Basis Points
|
||||||||||||||||
Type of
Instrument (1)
|
|
% of Market Value
|
|
% of Total Equity
|
|
% of Market Value
|
|
% of Total Equity
|
|
% of Market Value
|
|
% of Total Equity
|
|
% of Market Value
|
|
% of Total Equity
|
||||||||
RMBS
|
|
0.2
|
%
|
|
2.2
|
%
|
|
—
|
%
|
|
(0.2
|
)%
|
|
(0.7
|
)%
|
|
(6.9
|
)%
|
|
(1.8
|
)%
|
|
(17.6
|
)%
|
CMBS
|
|
1.4
|
%
|
|
13.5
|
%
|
|
2.9
|
%
|
|
27.6
|
%
|
|
(1.3
|
)%
|
|
(12.8
|
)%
|
|
(2.6
|
)%
|
|
(25.0
|
)%
|
CMBS IO
|
|
0.1
|
%
|
|
0.9
|
%
|
|
0.2
|
%
|
|
2.0
|
%
|
|
(0.1
|
)%
|
|
(1.0
|
)%
|
|
(0.2
|
)%
|
|
(2.0
|
)%
|
TBAs
|
|
0.1
|
%
|
|
0.7
|
%
|
|
0.1
|
%
|
|
0.7
|
%
|
|
(0.1
|
)%
|
|
(1.3
|
)%
|
|
(0.3
|
)%
|
|
(3.0
|
)%
|
Interest rate hedges
|
|
(1.7
|
)%
|
|
(16.3
|
)%
|
|
(3.5
|
)%
|
|
(33.5
|
)%
|
|
1.6
|
%
|
|
15.5
|
%
|
|
3.2
|
%
|
|
30.1
|
%
|
Total
|
|
0.1
|
%
|
|
1.0
|
%
|
|
(0.4
|
)%
|
|
(3.4
|
)%
|
|
(0.7
|
)%
|
|
(6.5
|
)%
|
|
(1.8
|
)%
|
|
(17.3
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
December 31, 2018
|
||||||||||||||||||||||
|
|
Decrease in Interest Rates by
|
|
Increase in Interest Rates by
|
||||||||||||||||||||
|
|
50 Basis Points
|
|
100 Basis Points
|
|
50 Basis Points
|
|
100 Basis Points
|
||||||||||||||||
Type of
Instrument (1)
|
|
% of Market Value
|
|
% of Total Equity
|
|
% of Market Value
|
|
% of Total Equity
|
|
% of Market Value
|
|
% of Total Equity
|
|
% of Market Value
|
|
% of Total Equity
|
||||||||
RMBS
|
|
1.0
|
%
|
|
7.0
|
%
|
|
1.6
|
%
|
|
11.2
|
%
|
|
(1.3
|
)%
|
|
(9.4
|
)%
|
|
(2.9
|
)%
|
|
(20.6
|
)%
|
CMBS
|
|
1.0
|
%
|
|
7.1
|
%
|
|
2.0
|
%
|
|
14.6
|
%
|
|
(1.0
|
)%
|
|
(6.8
|
)%
|
|
(1.9
|
)%
|
|
(13.4
|
)%
|
CMBS IO
|
|
0.3
|
%
|
|
1.8
|
%
|
|
0.4
|
%
|
|
3.1
|
%
|
|
(0.1
|
)%
|
|
(0.7
|
)%
|
|
(0.3
|
)%
|
|
(1.9
|
)%
|
TBAs
|
|
0.2
|
%
|
|
1.7
|
%
|
|
0.4
|
%
|
|
2.5
|
%
|
|
(0.4
|
)%
|
|
(2.9
|
)%
|
|
(0.9
|
)%
|
|
(6.7
|
)%
|
Interest rate hedges
|
|
(2.7
|
)%
|
|
(19.0
|
)%
|
|
(5.5
|
)%
|
|
(39.0
|
)%
|
|
2.5
|
%
|
|
18.1
|
%
|
|
4.9
|
%
|
|
35.3
|
%
|
Total
|
|
(0.2
|
)%
|
|
(1.4
|
)%
|
|
(1.1
|
)%
|
|
(7.6
|
)%
|
|
(0.3
|
)%
|
|
(1.7
|
)%
|
|
(1.1
|
)%
|
|
(7.3
|
)%
|
(1)
|
Changes in market value of our financings are excluded because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||||
Basis Point Change in
|
|
Percentage Change in
|
||||||||||||
2-year UST
|
|
10-year UST
|
|
Market Value of Investments (1)
|
|
Shareholders’ Equity
|
|
Market Value of Investments (1)
|
|
Shareholders’ Equity
|
||||
+25
|
|
+50
|
|
(0.5
|
)%
|
|
(5.0
|
)%
|
|
(0.1
|
)%
|
|
(0.8
|
)%
|
+50
|
|
+25
|
|
(0.4
|
)%
|
|
(4.1
|
)%
|
|
(0.2
|
)%
|
|
(1.1
|
)%
|
+50
|
|
+100
|
|
(1.5
|
)%
|
|
(14.4
|
)%
|
|
(0.8
|
)%
|
|
(5.7
|
)%
|
-25
|
|
0
|
|
0.1
|
%
|
|
1.1
|
%
|
|
0.2
|
%
|
|
1.4
|
%
|
-25
|
|
-75
|
|
(0.2
|
)%
|
|
(1.8
|
)%
|
|
(0.8
|
)%
|
|
(5.4
|
)%
|
-50
|
|
-10
|
|
0.2
|
%
|
|
2.3
|
%
|
|
0.3
|
%
|
|
1.8
|
%
|
-75
|
|
-25
|
|
0.3
|
%
|
|
2.8
|
%
|
|
0.2
|
%
|
|
1.7
|
%
|
(1)
|
Includes changes in market value of our investments and derivative instruments, including TBA securities, but excludes changes in market value of our financings because they are not carried at fair value on our balance sheet. The projections for market value do not assume any change in credit spreads.
|
|
|
June 30, 2019
|
|
December 31, 2018
|
||||||||
|
|
Percentage Change in
|
||||||||||
Basis Point Change in Market Spreads
|
|
Market Value of Investments (1)
|
|
Shareholders’ Equity
|
|
Market Value of Investments (1)
|
|
Shareholders’ Equity
|
||||
+20/+50 (2)
|
|
(1.1
|
)%
|
|
(10.7
|
)%
|
|
(1.3
|
)%
|
|
(9.5
|
)%
|
+10
|
|
(0.5
|
)%
|
|
(5.0
|
)%
|
|
(0.6
|
)%
|
|
(4.5
|
)%
|
-10
|
|
0.5
|
%
|
|
5.2
|
%
|
|
0.7
|
%
|
|
5.0
|
%
|
-20/-50 (2)
|
|
1.2
|
%
|
|
11.0
|
%
|
|
1.5
|
%
|
|
11.0
|
%
|
(1)
|
Includes changes in market value of our MBS investments, including TBA securities.
|
(2)
|
Assumes a 20-basis point shift in Agency and non-Agency RMBS and CMBS and a 50-basis point shift in Agency and non-Agency CMBS IO.
|
ITEM 4.
|
CONTROLS AND PROCEDURES
|
PART II.
|
OTHER INFORMATION
|
ITEM 1.
|
LEGAL PROCEEDINGS
|
Exhibit No.
|
Description
|
3.1
|
|
3.1.1
|
|
3.2
|
|
10.23.5
|
|
10.23.6
|
|
10.24.2
|
|
10.35.1
|
|
31.1
|
|
31.2
|
|
32.1
|
|
101
|
The following materials from Dynex Capital, Inc.'s Quarterly Report on Form 10-Q for the three months ended June 30, 2019, formatted in iXBRL (Inline Extensible Business Reporting Language), filed herewith: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income (Loss), (iii) Consolidated Statements of Shareholders’ Equity, (iv) Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Consolidated Financial Statements.
|
|
|
DYNEX CAPITAL, INC.
|
|
|
|
|
|
|
Date:
|
August 6, 2019
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Chief Executive Officer, President,
|
|
|
Co-Chief Investment Officer, and Director
|
|
|
(Principal Executive Officer)
|
|
|
|
Date:
|
August 6, 2019
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Executive Vice President, Chief Financial Officer and Chief Operating Officer
|
|
|
(Principal Financial Officer)
|
By:
|
/s/ Stephen J. Benedetti
Name: Stephen J. Benedetti Title: President |
By:
|
/s/ Robert M. Nilson, Jr.
Name: Robert M. Nilson, Jr. Title: Senior Vice President |
By:
|
/s/ John Rhee
Name: John Rhee Title: Managing Director |
By:
|
/s/ Stephen J. Benedetti
Name: Stephen J. Benedetti Title: Executive Vice President, Chief Financial Officer and Chief Operating Officer |
By:
|
/s/ Jeff Childress
Name: Jeff Childress Title: Vice President |
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Dynex Capital, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
August 6, 2019
|
|
|
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Principal Executive Officer
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Dynex Capital, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
August 6, 2019
|
|
|
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Principal Financial Officer
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
August 6, 2019
|
/s/ Byron L. Boston
|
|
|
Byron L. Boston
|
|
|
Principal Executive Officer
|
|
|
|
|
|
|
Date:
|
August 6, 2019
|
/s/ Stephen J. Benedetti
|
|
|
Stephen J. Benedetti
|
|
|
Principal Financial Officer
|